Coagulation responses to acute and chronic stress by Merz, Franziska
  
Aus dem Max-Planck-Institut für Psychiatrie 
 
 
Direktor: Prof. Dr. Dr. Martin E. Keck 
 
 
Coagulation responses to acute and chronic stress – a comparison 
between remitted depressed patients and healthy controls 
 
 
 
Dissertation 
zum Erwerb des Doktorgrades der Medizin 
an der Medizinischen Fakultät der 
Ludwig-Maximilians-Universität München 
 
 
 
 
 
vorgelegt von 
Franziska Merz 
aus Starnberg 
 
  
  
 
2 
 
 
Mit Genehmigung der Medizinischen Fakultät 
der Universität München 
 
 
 
1. Berichterstatter:                     Prof. Dr. Dr. Dr. h.c. Florian Holsboer 
Mitberichterstatter:         Prof. Dr. Michael Spannagl     
       Priv. Doz. Dr. Cornelius Schüle 
 
 
 
Mitbetreuung durch den  
promovierten Mitarbeiter:            Dr. phil. Marcus Ising 
Dekan:                                          Prof. Dr. med. dent. Reinhard Hickel 
 
Tag der mündlichen Prüfung:      22.12.2016 
  
  
 
3 
 
 
 
 
 
 
 
 
 
für meine Familie 
  
 
4 
Contents 
 
Summary .................................................................................................................................... 6 
Abbreviations ............................................................................................................................. 8 
Figures and Tables ..................................................................................................................... 9 
1. Introduction ....................................................................................................................... 10 
2. Theoretical background and current research ................................................................... 11 
2.1. The physiology of the stress reaction: the SNS and the HPA-axis ............................ 11 
2.2. Virchow’s triad and plaque formation ........................................................................ 13 
2.3. Hemostasis, coagulation and fibrinolysis ................................................................... 16 
2.4. Depression and the coagulation system ...................................................................... 19 
2.5. Acute and chronic stress and the coagulation system ................................................ 19 
2.6. Coagulation markers for acute and chronic stress ...................................................... 22 
3. Research questions and hypotheses ................................................................................... 25 
3.1. Hypotheses regarding basal coagulation .................................................................... 25 
3.1.1. The effects of remitted depression on basal coagulation .................................... 25 
3.1.2. The effects of chronic stress on basal coagulation .............................................. 26 
3.1.3. The effects of the interaction between remitted depression and chronic stress on 
basal coagulation ................................................................................................. 27 
3.2. Hypotheses regarding stress-induced coagulation ..................................................... 27 
3.2.1. The effects of remitted depression on stress-induced coagulation ...................... 27 
3.2.2. The effects of chronic stress on stress-induced coagulation ............................... 28 
3.2.3. The effects of the interaction between remitted depression and chronic stress on 
stress-induced coagulation .................................................................................. 28 
4. Methods ............................................................................................................................. 29 
4.1. Subject Sample ........................................................................................................... 29 
4.2. Experimental procedure ............................................................................................. 32 
4.3. Assessment of the stress response .............................................................................. 34 
4.4. Sampling procedure and laboratory analyses ............................................................. 35 
4.5. Questionnaires ............................................................................................................ 36 
4.6. Statistical analyses ...................................................................................................... 38 
5. Results ............................................................................................................................... 41 
5.1. Demographics ............................................................................................................. 41 
5.2. Resting coagulation parameters .................................................................................. 43 
  
 
5 
5.2.1. Fibrinogen ........................................................................................................... 43 
5.2.2. D-Dimer .............................................................................................................. 43 
5.2.3. VWF .................................................................................................................... 44 
5.2.4. PAI-1 ................................................................................................................... 45 
5.3. Stress induction: effects of the TSST paradigm ......................................................... 45 
5.3.1. Heart rate response .............................................................................................. 45 
5.3.2. Cortisol response ................................................................................................. 46 
5.3.3. Perceived stress ................................................................................................... 47 
5.4. Stress-induced coagulation changes ........................................................................... 48 
5.4.1. Fibrinogen ........................................................................................................... 49 
5.4.2. D-Dimer .............................................................................................................. 51 
5.4.3. VWF .................................................................................................................... 52 
5.5. Associations between depression symptoms and chronic stress load, and hemostatic 
markers ....................................................................................................................... 53 
6. Discussion ......................................................................................................................... 56 
6.1. Coagulation markers at rest ........................................................................................ 56 
6.1.1. The effects of remitted depression on basal coagulation .................................... 56 
6.1.2. The effects of chronic stress on basal coagulation .............................................. 57 
6.1.3. Interaction effects between remitted depression and chronic stress on basal 
coagulation .......................................................................................................... 58 
6.2. Stress-induced changes .............................................................................................. 58 
6.2.1. The effects of remitted depression on stress-induced coagulation ...................... 59 
6.2.2. The effects of chronic stress on stress-induced coagulation ............................... 60 
6.2.3. Interaction effects between remitted depression and chronic stress on stress-
induced coagulation ............................................................................................ 61 
6.3. Associations between chronic stress and hemostasis ................................................. 61 
6.4. Strengths and limitations ............................................................................................ 62 
6.5. Conclusion and outlook .............................................................................................. 64 
Literature .................................................................................................................................. 68 
Appendix I. ............................................................................................................................... 78 
Appendix II. ............................................................................................................................. 83 
Eidesstattliche Versicherung .................................................................................................... 86 
  
 
6 
Summary 
An increased risk of cardiovascular morbidity and mortality has been demonstrated in studies 
on depressed individuals. 
One of the mechanisms discussed to explain this relationship is an imbalance in the hemostat-
ic system.  
From an evolutionary perspective it appears plausible that stress-procoagulability is a benefi-
cial adaptation to protect an organism from excessive bleeding in fight-flight situations. How-
ever, an imbalance of this system is harmful as a shift toward a hypercoagulable state contrib-
utes to atherosclerosis formation and acceleration of existing atherosclerotic plaques. 
In depression, such hypercoagulable states have been frequently described – both at rest and 
in response to acute stress. Depression as a stress-related disease is often concurrent with 
chronic stress, as well as with hypothalamic-pituitary-adrenal (HPA)-axis alterations. A cen-
tral question of this work is whether chronic stress and depression are independent factors 
influencing basal and stress-induced coagulation, or if they potentially have an interacting 
effect. 
In the present study the procoagulant factors fibrinogen, D-Dimer, Von-Willebrand-Factor 
(VWF) and the antifibrinolytic factor plasminogen-activator-inhibitor (PAI-1) were measured 
in 63 subjects from an epidemiological sample, who were recruited for presence and absence 
of a history of major depression into a remitted major depression group (MD) and a control 
group. Further, the participants were divided into groups of high and low chronic stress (CS). 
All four coagulation factors were measured at baseline and all but PAI-1 were measured also 
following a psychosocial stress test. To evaluate chronic stress the Trier inventory of chronic 
stress (TICS) was employed while acute stress was elicited using a well-established psycho-
social stress test, the Trier Social Stress Test (TSST). This 13-minute test combines prepara-
tion, a mock job interview and a mental arithmetic task in front of an evaluating audience. 
The following results were observed: fibrinogen was higher in the remitted depression group 
at baseline and depression history had a significant effect also on stress-induced changes in 
fibrinogen. A large body of research has identified fibrinogen as a potential marker for an 
increased cardiovascular risk in depression, and even a marker for depression. The latter was 
supported by our findings. Furthermore, a trend toward higher D-Dimer levels at rest in 
chronically stressed subjects was observed. CS had an effect on stress-induced D-Dimer in-
creases, which was independent from a history of major depression. 
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Unlike previous research this work does not observe differences in VWF and PAI-1 plasma 
concentrations between the MD and CS groups, neither at rest nor following the stress test.  
Novel in this study was that the recruited subjects were in remission from major depressive 
disorder (as diagnosed using DSM-IV) for at least 6 months. This work adds to the existing 
knowledge regarding fibrinogen as a potential marker for depression in that it identified fi-
brinogen as also being increased in cases of remitted depression.   
Further research is needed to investigate the role of fibrinogen in remitted depression.  
In particular, interventional studies examining the effect of known treatments of depression 
on fibrinogen levels are needed. It would be advisable that physicians treating depression are 
aware of their patients’ cardiovascular risk factors and that they give depression, and also 
remitted depression, the same amount of attention as a traditional cardiovascular risk factor. 
Monitoring fibrinogen in depressed patients should be considered a real option in the future. 
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1. Introduction 
Depression is a debilitating disease with a high socioeconomic impact. Its lifetime prevalence 
ranges between 10 and 15% (Lépine & Briley, 2011) and the World Health Organization pro-
jects that by 2020, depression will be the second leading cause for disability (Murray & 
Lopez, 1996). An overall relative risk of 1.64 for the development of coronary heart disease in 
depressed subjects has been described (Rugulies, 2002) and the risk for cardiac mortality is 
increased in patients with major depressive disorder (Carney & Freedland, 2008; Cuijpers & 
Smit, 2002; Nemeroff & Goldschmidt-Clermont, 2012; Von Känel et al., 2013). 
One factor that might account for the elevated risk for cardiac events in depression is an im-
balance between coagulation and fibrinolysis (Bacon et al., 2006; Hemingway & Marmot, 
1999; Surtees et al., 2008; Von Känel, Dimsdale, et al., 2004). 
While coagulation is an interaction of various factors that causes „thickening of the 
blood“,expressed colloquially, fibrinolysis reverses this process by “dissolving coagulated 
blood“. Coagulation and fibrinolysis work together in order to ensure optimal functioning of 
blood flow and to repair vessel wall lesions. In many healthy subjects, coagulation, as well as 
fibrinolysis are activated simultaneously as a response to acute mental stress, with the balance 
shifted toward a progoaculant milieu (Hjemdahl & Von Känel, 2012). From an evolutionary 
standpoint a procoagulant response is biologically sensible in that it may protect the organism 
from possible blood loss during a fight-or-fight situation.  
In patients with impaired endothelial function, i.e. arteriosclerosis, coagulation constantly 
outweighs fibrinolysis thereby resulting in a hypercoagulable state that increases the risk for 
cardiovascular events such as myocardial infarction or ischemic stroke. Several studies sug-
gest that in depression, there also exists a shift towards a hypercoagulable state (Lahlou-
Laforet et al., 2006; Tsai, Hong, Liou, Yu, & Chen, 2008; Von Känel, Bellingrath, & 
Kudielka, 2009a; Wium-Andersen, Orsted, & Nordestgaard, 2013) which could explain the 
increased cardiovascular mortality in these depressed patients (Tsai et al., 2008). 
 
Despite the fact that well known risk factors such as hypertension, dyslipidemia, and diabetes 
history are not generally seen in depression, the cardiovascular risk is still increased. A com-
mon element seen in both classical risk factors and depression is an elevation in fibrinogen. 
The relationships between impaired hemostasis, stress and depression are not yet fully under-
stood. This work attempts to make a contribution to understanding them better. 
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2. Theoretical background and current research 
This chapter gives a summary of the theoretical background of the study. First, the major 
stress response systems, the sympathetic nervous system (SNS) and the hypothalamus-
pituitary-adrenocortical (HPA) axis will be introduced, followed by a description of Vir-
chow’s triad: it serves as the foundation for understanding how changes in blood composition, 
alterations in blood flow, and vascular endothelial injury, can elevate the risk for thrombosis. 
Since a major aspect of this triad is hypercoagulability, the coagulation system will be de-
scribed. Finally, the current state of research regarding the role of depression, acute and 
chronic stress on the coagulation system will be summarized. 
2.1. The physiology of the stress reaction: the SNS and the HPA-axis  
One of the pioneers in the area of stress research, Hans Selye described “stress as the failure 
to respond appropriately to emotional or physical threats to the organism, whether actual or 
imagined” (Selye, 1956 , as cited in Hamer & Malan, 2010). A breaking down of efficient 
adaptation mechanisms to chronic stress over long periods of time is harmful and can lead to 
disease. The two major stress response systems are the sympathetic adrenal medulla (SAM) 
axis as part of the autonomic nervous system, and the hypothalamic pituitary adrenal (HPA) 
axis (Houtveen, 2001). An understanding of these stress systems is relevant for this work be-
cause overactivities of both systems have been described in depression (Von Känel & Bacon, 
2013) and because a dysregulation of the HPA-axis may also influence the vascular system 
negatively. In cases of chronic stress and depression, HPA-axis alterations may be responsible 
for disturbed hemostatic and endothelial function (Von Känel & Bacon, 2013), which may 
explain increased cardiovascular morbidity in these patient groups. 
The Sympathetic-Adrenal-Medulla (SAM) axis  
The hypothalamus as the subordinate structure of the autonomic nervous system regulates 
both the sympathetic and parasympathetic nervous systems. It initiates the release of nora-
drenaline from post-ganglionic sympathetic neurons and the release of adrenaline and nora-
drenaline from adrenal medulla (SAM). 
The main function of this system is to maintain an equilibrium that ensures external demands 
on the organism can be met. This equilibrium, which Cannon termed ‘homeostasis’ (Cannon, 
1915) is important, for example, when the body faces increased energy demands during exer-
cise or in a ‘fight-flight’ situation. The responsiveness of the SAM system is immediate and 
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allows the organism to react without delay, for example by raising blood pressure and heart 
rate and initiating vasoconstriction.  
The Hypothalamic-Pituitary-Adrenal (HPA) axis 
In response to stress, corticotropin-releasing hormone (CRH) is released from neurosecretory 
nerve terminals in the hypothalamus, then transported to the anterior pituitary. Here CRH, 
together with vasopressin, acts to stimulate secretion of ACTH into the bloodstream. Once at 
the adrenals, ACTH initiates the synthesis of corticosteroids such as cortisol. Cortisol’s func-
tions include raising of blood sugar, modulation of the immune system and anti-inflammatory 
actions. Further, cortisol is a catabolic and lipogenic hormone. 
 
The HPA-axis is regulated by a negative feedback mechanism by which cortisol receptors in 
the brain and at the pituitary inhibit further synthesis and release of both CRH and ACTH, 
respectively. The humoral HPA-axis response is markedly slower than the nervous SAM re-
sponse. Furthermore, cortisol acts via translocation of the activated glucocorticoid receptor on 
the transcriptional or genomic level and therefore its effects are further delayed.  
In depression, a desensitization of the glucocorticoid receptor for cortisol leads to an insuffi-
cient negative feedback and to increased CRH, cortisol and arginine-vasopressin levels  
(Binder, 2009). Depressed patients show impairments in HPA-axis regulation, as studies in-
volving the combined Dexamethasone/CRH-Suppression-Test have shown: depressed indi-
viduals respond to a CRH injection under the suppressive effects of dexamethasone with ex-
aggerated ACTH and cortisol levels, whereas the CRH effects under dexamethasone suppres-
sion are considerably blunted in healthy subjects (Ising et al., 2007). 
 
Cortisol and the CRH can further influence synthesis and release of serotonin, norepinephrine 
and dopamine and modulate their receptors. Hypersecretion of these hormones can lead to the 
clinical manifestations of depression and anxiety, mainly through actions on limbic and neo-
cortical structures (Holsboer & Ising, 2010). A dysregulation of the HPA-axis may also 
influence the vascular system: in chronic stress and depression, HPA-axis alterations may be 
responsible for disturbed hemostatic and endothelial function (Von Känel & Bacon, 2013). In 
a placebo-controlled trial, Brotman et al., (2006) showed that a 5-day treatment course of 
dexamethasone in healthy men increased circulating levels of fibrinogen, and the procoagu-
lant factors VII, VIII and XI.  
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Although SAM and HPA systems seem to serve different purposes, aspects of interdependen-
cy of the two systems exist: cortisol as part of the HPA-system may be involved in modifica-
tion of sensitivity of adreno-receptors (Houtveen, 2001; Kvetnansky et al., 1995), which be-
long to the SAM system, and further, CRH gene expression can be altered by catecholamines 
(Kaminski & Watts, 2013).  
2.2. Virchow’s triad and plaque formation 
The psychophysiological mechanisms linking depression and stress to coronary artery dis-
ease, and ultimately cardiovascular events such as stroke or myocardial infarction, have not 
been fully elucidated (Von Känel, Bellingrath, et al., 2009a). Recent research suggests that a 
hypercoagulable state may contribute to the progression of atherosclerosis and atherosclerotic 
plaque rupturing, and ultimately leading to myocardial infarction (Von Känel & Bacon, 
2013). Such a hypercoagulable state, i.e. increased clotting, decreased fibrinolytic activity and 
impairments of the endothelium, has also been described in depression and may be one im-
portant element to link depression with increased cardiovascular risk. Particularly autonomic 
dysfunction and alteration in the hypothalamic pituitary adrenal axis might mediate perturbed 
hemostatic and endothelial function under chronic stress and negative affect, e.g., depression 
or anxiety (Von Känel & Bacon, 2013). 
 
Hypercoagulability, hemodynamic changes and endothelial dysfunction, also known as ‘Vir-
chow's triad’ (Figure 1), describe properties of the vascular system that constitute risk factors 
for thrombosis and, ultimately, cardiovascular events such as myocardial infarction or stroke 
caused by thromboembolisms (Chung & Lip, 2003). It is important to note that Virchow’s 
triad is complemented by inflammatory processes to ultimately increase the risk for cardio-
vascular events, as Figure 1 shows. 
Hypercoagulability 
Hypercoagulability describes a shift toward a ‘thickening of the blood’ through activation of 
platelets and the synthesis and activation of procoagulant factors. The procoagulant factors, 
thrombin and fibrin are formed in a complex cascade-like manner that involves multiple fac-
tors, as Figure 2 Shows. Triggers for hypercoagulability may be an activation of the sympa-
thetic nervous system (Von Känel & Dimsdale, 2000) 
  
 
14 
Hemodynamic changes 
Whenever blood flow is slowed down, the chance of turbulences and therefore the risk for 
thrombus formation is increased. Causes for slowing of blood flow can be shifts in the com-
position of blood, for example through exsiccosis, increases in platelet count (thrombocyto-
sis), or obstruction of the vessel lumen through atherosclerotic plaques.  
Endothelial damage 
The healthy endothelium possesses anticoagulant, antiplatelet and fibrinolytic mechanisms 
and releases vasodilative nitric oxide to maintain vascular tone and structure and proper blood 
flow (Davignon & Ganz, 2004).  
These mechanisms can be disturbed in a variety of ways: through inflammatory processes, 
increased permeability of the endothelium, a procoagulant milieu and diminished production 
of nitric oxide, which acts anti-atherogenic by inhibiting cellular adhesion, migration and pro-
liferation (Ross, 1999). In major depression lower nitric oxide activity has been reported to-
gether with increased levels of reactive oxygen species (Chrapko et al., 2004); both of which 
point to a compromised endothelium (Von Känel & Bacon, 2013). 
The acute phase fibrinogen which is studied in the present work has been identified as being 
involved in the pathogenesis of atherosclerosis in that it increases endothelial permeability, 
platelet reactivity, monocyte migration, LDL accumulation and formation of foam cells 
(Borissoff, Spronk, & Cate, 2011). The large population-based, prospective, observational 
CARDIA study (Green et al., 2010) revealed a significant association between fibrinogen 
levels and enhanced rate of coronary-artery calcification and carotid intima-media thickness 
over a 13-year study interval. Young subjects with elevated fibrinogen levels were more like-
ly to exhibit these two precursory signs for atherosclerosis in middle age.   
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Figure 1. Virchow’s triad and cardiovascular risk. The relationships between depression, stress and the 
hemostatic system. Blue boxes indicate that these elements belong to ‘Virchow’s triad’. Based on: Austin, 
Wissmann, & Von Känel (2013). 
 
The hemostatic system and atherosclerotic plaque formation  
When the endothelium lining the inner wall of a blood vessel is damaged, for example 
through small lesions caused by hypertension, the protein VWF becomes exposed. Platelets 
present in the blood that bypass this damaged site bind to VWF via their glycoprotein Ib-
alpha receptors. Once adherent to the site of injury, platelets secrete mediators such as cyto-
kines, chemokines, growth factors and the intrinsic components of the coagulation system. 
These interact with leukocytes and dendritic cells and commence the complicated process of 
atherosclerotic plaque formation. (Borissoff et al., 2011). It is believed that a procoagulant 
environment will gradually promote pre-existing atherosclerosis through deposits of fibrin in 
the vessel wall and through inflammatory processes (Borissoff et al., 2011; Falk & 
Fernández-Ortiz, 1995). Ruptured plaques are carried away with the bloodstream and may 
occlude coronary arteries and cerebral vessels, causing myocardial infarction and stroke, re-
spectively.  
Risk for 
cardiovascular event 
increases
Endothelial dysfunction
Chronic stressors (job strain, PTSD…), depression
Inflammation
Progression of existing 
atherosclerosis
Hypercoagulable state
Hemodynamic changes
Risk for thrombogenesis
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2.3. Hemostasis, coagulation and fibrinolysis 
Hemostasis describes the end result of the interaction of the platelet system with coagulant 
and anti-coagulant influences. It aims to support a dynamic equilibrium that allows proper 
blood flow and, ensures the vessel wall is sealed to prevent blood loss in case of injury (Furie 
& Furie, 2008). Since hemostasis is a very complex system, its components relevant to the 
present work shall be described here in a simplified manner. There are four steps involved in 
hemostasis: first, primary hemostasis as the initiation of the platelet plug, second, the coagula-
tion cascade with its extrinsic and intrinsic paths; third, the cessation of further thrombus for-
mation by antithrombotic mechanisms; and fourth, fibrinolysis, which removes the clot 
(Leung, 2014). The coagulation cascade, which consists of the intrinsic and extrinsic systems, 
leads to formation of fibrin polymers which consolidate the platelet plug that had been formed 
during primary hemostasis (Halperin & Reber, 2007). 
The intrinsic pathway of coagulation 
When blood comes into contact with damaged tissue, platelets become activated. An example 
where damaged tissue is exposed are minute lesions that happen many times daily even in 
healthy persons. These activated platelets expose negatively charged surfaces that activate the 
plasma protein Factor XII. Factor XII, like all components of the intrinsic system, is always 
present in the blood. As figure 2 depicts, activation of Factor XII sets into motion a cascade of 
activation of other plasma proteins that result in the formation of activated factor X, the end 
product of both the extrinsic and intrinsic systems.  
The extrinsic pathway of coagulation 
The extrinsic path is a fast-response system that is set into action once tissue factor (Factor 
VII) in the endothelial cells becomes exposed through injury. Activated Factor VII then also 
activates Factor X, at which point the two pathways merge. 
 
Both pathways can also be activated without overt injury to the endothelium, which is particu-
larly the case in stress-induced coagulation, as is examined in this work.  
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Figure 2. The hemostatic pathways. The fast-acting extrinsic and slower intrinsic coagulation pathways 
converge at Factor Xa, which ultimately converts pro-thrombin to thrombin. Thrombin, in turn converts 
fibrinogen to fibrin which binds platelets to one another to form a thrombus. Factor V, calcium ions (Ca++ 
and phospholipids of platelet membrane (PL) act as co-activators in thrombin formation. The steps in 
which fibrin is broken down into fibrin degradation products, or D-Dimers is known as fibrinolysis. The 
factors examined in this work (VWF, Fibrinogen, D-Dimers) are marked by boxes. ‘a’ stands for the acti-
vated form of the coagulation factor. 
Both systems are connected via the common Factor X, as shown in figure 2. Moreover, VWF 
facilitates the adherence of platelets to injury sites. VWF and platelets belong neither to the 
extrinsic nor the intrinsic pathway, they can be seen more as links between the two systems.  
From an evolutionary point of view, hemostasis serves as a beneficial adaptation mechanism, 
in that it protects the organism from bleeding in fight-flight situations. As a response to acute 
stress, epinephrine and norepinephrine as part of the SAM-axis stimulate the release of certain 
procoagulant factors (FVIII, VWF and tissue plasminogen activator) via action on beta-
adrenergic sympathetic endothelial receptors. Further, epinephrine and norepinephrine acti-
vate platelets via alpha2-adrenergic receptors (Von Känel & Dimsdale, 2000). 
Fibrinolysis 
The opposing mechanism to coagulation is fibrinolysis. Its participating components are de-
picted in Figure 3. Without this plasma protein system, a thrombus would continue to get 
larger, as it further stimulates platelets and the coagulation cascade in a positive-feedback 
loop (Austin, Patterson, & Von Känel, 2011).  
Prothrombin Thrombin 
Fibrinogen Fibrin
Intrinsic pathway Extrinsic pathway
XII
XI
XIIa
XIa
IX IXa
VIIa(tissue factor)
Tissue damage
XXa
stable fibrin
clot
X
Negative charges on activated platelets
Platelets
D-Dimers
VWF
V, Ca++, PL
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Figure 3. Fibrinolysis as the opposing mechanism to coagulation. As plasmin acts on fibrin, a thrombus is 
prevented from growing and is broken down. Plasminogen-activator inhibitor acts as a procoagulant fac-
tor via its inhibitory effects on t-PA and Urokinase. 
Before describing some of the important research regarding the selected coagulation markers 
and their relations to depression and stress, an overview of the changes that previous research 
has described is presented (See Table 4). 
Table 4. Overview of previous findings regarding the effects of depression, acute and chronic stress on 
hemostatic markers.(↑Increases with stressor, - no response); as in Mills & Von Känel (2010). 
 
 
Major Depression 
 
Acute stress Chronic stress 
 
HPA-axis dysregulation Mainly SNS activation 
Psychosocial stress: also 
HPA-axis activation 
Predominantly HPA-axis 
activation 
Fibrinogen Resting levels↑ ↑ ↑ 
D-Dimer Attenuated response to acute 
stress and prolonged recovery 
↑post stress 
↑ ↑ 
VWF - ↑ ↑/- 
PAI-1 Resting levels ↑ - ↑ 
 
Plasminogen
Plasmin
Fibrin
Fibrin 
degradation
products:
D-Dimer
Tissue plasminogen 
activator (tPA)
Urokinase
Plasmin activator 
inhibitor
PAI-1 
+
_
_
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2.4. Depression and the coagulation system 
Depression is associated with increased levels of fibrinogen (Martins-de-Souza et al., 2014; 
Wium-Andersen, Orsted, et al., 2013; Wium-Andersen, Ørsted, & Nordestgaard, 2013) and 
increases in depressive symptoms have been described to correlate with elevated fibrinogen 
levels in an examination of healthy school teachers over a 2-year period (Von Känel, 
Bellingrath, & Kudielka, 2009b). Further, studies on platelets and psychiatric disease revealed 
altered platelet functioning in depression. Increased aggregability to the stimulators thrombin 
and collagen (Lederbogen et al., 2001), as well as heightened reactivity to orthostatic stress 
(Musselman et al., 1996) were demonstrated in major depression patients compared to con-
trols. Interestingly, platelets store large amounts of serotonin (Williams, 2012), and in depres-
sion, storage and metabolism of this neurotransmitter, as well as noradrenergic and sero-
tonergic receptor density have been shown to be altered (Musselman et al., 1996).  
Research by von Känel et al. (2009) showed associations of severity of depression symptoms 
and vital exhaustion with attenuated D-Dimer responses to acute stress, but a delayed D-
Dimer recovery (Von Känel et al. 2009a). A study on elderly persons found that depressive 
symptoms were associated with D-Dimer increases after exposure to an acute psychosocial 
stressor (Von Känel, Dimsdale, et al., 2004). Eskandari et al. (2005) conducted a study on 
premenopausal women with major depressive disorder (MDD) and report increased resting 
levels of the antifibrinolytic PAI-1.  
2.5. Acute and chronic stress and the coagulation system 
Acute and chronic stress do not affect the hemostatic system in the same way (Mills & Von 
Känel, 2010). These differences are explained in the following paragraphs.  
Acute stress 
Acute stress activates the sympathetic nervous system, which affects the coagulation system 
in the following way: catecholamines are able to activate vascular endothelial beta-2 recep-
tors, resulting in increases of FVIII, VWF and t-PA. Catecholamines can further activate 
platelets (Halperin & Reber, 2007). Acute stress also causes hemoconcentration, a process in 
which increasing blood pressure causes efflux of plasma to the interstitial space. In hemocon-
centration, larger non-diffusible molecules including coagulation markers remain inside the 
vascular system thereby increasing in concentration (Austin et al., 2011, 2013).  
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The HPA-axis is activated by acute stress that includes a psychosocial component, as seen in 
plasma ACTH and cortisol (Bellingrath & Kudielka, 2008; Dickerson & Kemeny, 2004; 
Höhne et al., 2014) However, chronic stress seems to elicit larger reactions in the HPA-axis.  
The research literature describes a variety of ways to elicit acute stress in study participants in 
a laboratory setting, such as mental arithmetic tasks, speech tasks, the mirror star tracing task, 
and the Stroop color-word conflict test (Austin et al., 2013). 
Examinations of healthy subjects revealed increases of procoagulant markers in response to 
acute stress. Such markers were FVII, FVIII, FXII, fibrinogen, VWF antigen and platelets 
(Austin et al., 2011; Hjemdahl & Von Känel, 2012; Thrall, Lane, Carroll, & Lip, 2007; Von 
Känel et al., 2013; Von Känel, Mills, Fainman, & Dimsdale, 2001; Wirtz et al., 2008). How-
ever, the pro-fibrinolytic and anticoagulant factor tissue plasminogen activator (t-PA) was 
increased through acute stress as well in these studies, which indicates that both coagulation 
and fibrinolysis are activated at the same time (Austin et al., 2013; Hjemdahl & Von Känel, 
2012). However, it is suggested that procoagulant mechanisms outweigh fibrinolytic mecha-
nisms, which would result in net hypercoagulability. After exposure to acute stress, levels of 
coagulation factors returned to normal after 20-45 minutes, as two studies (Von Känel, 
Preckel, et al., 2004; Wirtz et al., 2008) have described. 
Chronic stress 
The literature describes different categories of chronic psychological stress, such as work 
stress, the stress of caregiving and post-traumatic stress disorder (PTSD), all of which have 
been associated with changes in coagulation (Austin et al., 2011).  
Cross-sectional studies have revealed associations f capacity (Hansen, Larsen, Rugulies, 
Garde, & Knudsen, 2009; Von Känel et al., 2001) Persons caring for their spouse with Alz-
heimer’s disease presented with higher resting D-Dimer levels than non-caregivers matched 
for age and sex (Von Känel, Dimsdale, et al., 2006). Research on PTSD patients showed an 
increased morbidity and a higher and more premature mortality due to cardiovascular disease 
and thromboembolism (Robicsek, Makhoul, Klein, Brenner, & Sarig, 2011). Higher levels of 
procoagulant hemostasis factors were described in PTSD patients compared to controls, for 
example VWF antigen and Factor VII (Robicsek et al., 2011). In addition, platelets from 
PTSD patients showed an increased reactivity to epinephrine/ADP stimulation (Vidović et al., 
2011) suggesting increased stress sensitivity.  
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Furthermore, socioeconomic class has been found to also influence the hemostatic system: 
fibrinogen, FVII:C and VWF:AG were found to be increased in persons with low socioeco-
nomic status, which was measured by constructs such as occupation and education (Von 
Känel et al., 2001). Low socioeconomic status has been treated as a form of chronic stress, 
however, one cannot make the claim that low social status always equates to chronic stress. 
Nonetheless, there exists some research that found connections between socioeconomic status 
and hemostatic changes. Von Känel et al., 2001, for example, summarize in their review on 
psychological stress and coagulation, that socioeconomic status is inversely related to plasma 
fibrinogen levels. A large public health survey by Berlin’s Robert Koch Institute on German 
adults, found that a high stress burden was more prevalent in persons with low socioeconomic 
status (Hapke et al., 2013). In this work, chronic stress was assessed by a questionnaire that 
focuses on work and social stress primarily. Although associations between socioeconomic 
status and the hemostatic system exist, this work does not examine social status of the sub-
jects.  
 
Regarding changes in coagulation, chronic stress seems to differ from acute stress in that it is 
more involved in HPA-axis activation and in decreased parasympathetic activity (Hjemdahl & 
Von Känel, 2012; Von Känel & Bacon, 2013). How cortisol affects the coagulation system 
has not been studied as extensively as catecholamine effects. In women with coronary artery 
disease, morning serum cortisol was modestly associated with prothrombotic activity (fibrin-
ogen and VWF) suggesting that by causing a hypercoagulable state, cortisol might be in part 
responsible for the formation atherosclerosis (Von Känel, Mausbach, Kudielka, & Orth-
Gomér, 2008). 
One coronary angiography study revealed that patients with hypercortisolism had excess cor-
onary calcifications and atherosclerotic coronary plaques (Neary et al. 2013). Erem et al. 
(2009) found that in patients suffering from Cushing’s syndrome increased platelet count, 
fibrinogen and PAI-1, and decreased tissue factor pathway inhibitor were measured, which, in 
summary, confirm a hypercoagulable and hypofibrinolytic state. This evidence strengthens 
the argument for an association between cortisol and augmented risk for atherosclerosis. Our 
study sample did not include any persons with clinical hypercortisolism. Nonetheless, the 
relationship between a disturbance in HPA-axis regulation, which is manifest in hypercorti-
solism, and atherosclerosis is worth mentioning here, because patients with depression also 
show alterations in HPA-axis regulation.  
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2.6. Coagulation markers for acute and chronic stress 
In light of recent research in the area of acute stress and coagulation, the following parameters 
were selected for examination in the present work: fibrinogen, D-Dimer, VWF and PAI-1. 
The subsequent section explains the functions of these parameters and summarizes their role 
in recent research. 
Fibrinogen 
Fibrinogen is a glycoprotein that is always present in plasma and plays a key role in thrombo-
cyte aggregation and fibrin synthesis. Receptors on activated thrombocytes bind fibrinogen so 
that it can cross-link thrombocytes. The serine-protease thrombin cleaves fibrinogen, thus 
converting it to fibrin. Fibrin forms strands of insoluble protein that bind to thrombocytes and 
are cross-linked with the help of Factor XIII. Fibrin then contracts and hardens and together 
with aggregated thrombocytes forms a clot that can seal the site of injury. 
 
A large-scale study of the general population by Wium-Andersen et al. (2013) found that ele-
vated plasma fibrinogen levels were associated with depression and psychological distress 
after adjusting for the confounders age, gender, smoking, BMI, physical activity and chronic 
stress. Beside its role in blood clotting, fibrinogen is also an important acute-phase-protein, 
i.e. a plasma protein that rises in concentration in response to inflammation. One of the func-
tions of an acute phase protein is to help the immune system fend off microbes. Although the 
mechanisms are not yet fully understood, fibrinogen is also related to increased cardiovascu-
lar risk: a meta-analysis showed that the hazard ratio per 1 g/L increase in normal fibrinogen 
levels was 1.8 for coronary heart disease and stroke (Danesh, Lewington, & Thompson, 
2005). As previously mentioned, fibrinogen levels have been found to be increased in depres-
sion, and it is responsive to both acute and chronic stress. An increase in fibrinogen triggered 
by psychophysiological stress was shown to be associated with stiffness of the carotid arteries 
(Ellins et al., 2008), which further underlines the role of stress as a mediator for cardiovascu-
lar risk.  
D-Dimer  
D-Dimer, which is a product of fibrin-degradation in fibrinolysis, is an overall indicator of 
activation of coagulation and fibrinolysis or fibrin turnover (Von Känel & Bacon, 2013). Dur-
ing coagulation the enzyme thrombin connects soluble fibrin molecules to form a fibrin-  
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meshwork. This meshwork is further stabilized through Factor XIII, which creates links be-
tween fibrin fibrils at their D-fragment sites, creating a meshwork structure that serves as the 
foundation of a thrombus. During thrombus degradation, plasmin cleaves this mesh at various 
sites, resulting in polymers of different sizes. Sites in which two fibrin proteofils were linked 
(the D-fragment sites) remain intact and can be detected by an immunoabsorbant assay using 
monoclonal antibodies to a specific epitope on the D-Dimer fragment.  
In clinical practice D-Dimer serves as a marker for ruling out the diagnoses pulmonary embo-
lism and thromboembolism. Levels below 500ng/ml make it unlikely that a thrombus is in the 
process of degradation.  
D-Dimer plays a pro-atherosclerotic role in macrophage function by enhancing the inflamma-
tory response during foam cell formation (Zhou, Yang, Zhou, & Rui, 2007).  
In a series of studies Von Känel et al. were able to show increases of D-Dimer in response to 
acute psychosocial stress (Von Känel, Preckel, et al., 2004; Von Känel, Bellingrath, et al., 
2009a; Wirtz, Redwine, Ehlert, & Von Känel, 2009). It has been further shown that it is in-
creased in inflammation (Borissoff et al., 2011; Zhou et al., 2007).  
Von-Willebrand-Factor (VWF) 
VWF is a very large protein released from stimulated or damaged endothelial cells and from 
thrombocytes. It triggers platelet adhesion to places of vascular injury in areas of high shear 
stress and stimulates the aggregation of platelets. 
In acute-stress tasks, including the Trier Social Stress Test (TSST), an increase of VWF has 
been observed (Mills & Von Känel, 2010). Von Känel and Dimsdale (2000) report a dose-
dependent stimulation of VWF antigen during a 15- to 40-min infusion of epinephrine, sug-
gesting VWF production can be stimulated by sympathetic nervous system activation. Posi-
tive associations between severity of PTSD symptoms and VWF levels have been reported 
(Von Känel, Hepp, et al., 2006, 2008). 
Plasminogen activator inhibitor (PAI1 or SERPINE1) 
Plasminogen activator inhibitor (PAI-1) is a protein that acts on  tissue plasminogen activator 
(t-PA) and Urokinase and prevents these enzymes from promoting plasmin production. Its 
action thereby prevents fibrinolysis and amplifies or prolongs coagulation. Figure 3 depicts 
the connection between PAI-1 and the coagulation cascade. Normally, the liver, adipocytes, 
smooth muscle cells and platelets synthesize PAI-1. In pathological conditions however, such 
as atherosclerosis, endothelial cells and other inflammatory-stimulated cells secrete increased 
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amounts of PAI-1 (Binder, 2002). Recent studies suggest a crucial role for PAI-1 in mediating 
stress-induced hypercoagulability and thrombosis (Jiang, Gingles, Olivier, Miles, & Parmer, 
2011) A study by Eskandari et al. (2005) on premenopausal women with major depressive 
disorder showed increased resting levels of PAI-1. Further, an independent association be-
tween high PAI-1 and long term psychiatric symptoms in middle-aged men has been de-
scribed by Huotari et al. (2010). Lahlou-Laforet et al. (2006) report an elevated PAI-1 activity 
in depressed patients after adjusting for the presence of chronic heart disease, smoking, tri-
glyceride concentration, hypertension, and body mass index. Subjects with vital exhaustion 
showed increased baseline PAI-1 levels (Von Känel, Frey, & Fischer, 2004). Furthermore, 
two of six known polymorphisms for the PAI-1 gene have been found more frequently in pa-
tients with major depressive disorder (Tsai et al., 2008). Tsai and his team conclude that in-
creased PAI-1 levels may be one factor in explaining the link between metabolic syndrome 
and depression. With respect to stress, PAI-1 activity increases have been observed in chronic 
stress, but it does not seem to be affected by acute stress (Mills & Von Känel, 2010). 
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3. Research questions and hypotheses 
The focus of this work lies on the examination of the influence of a depression history and 
chronic stress on basal and stress-related coagulation.  
Depression symptoms and chronic stressors, such as job strain, may influence vascular health 
by creating a low-grade hypercoagulable state (Austin et al., 2013). Net hypercoagulability 
within the vasculature may contribute to increasing the risk for thrombogenesis and elicit pro-
gression of atherosclerotic plaques. The result is an increased risk for cardiovascular events, 
such as stroke or myocardial infarction. The following two sets of research questions will be 
addressed to help to better understand these associations. 
The first set of research questions deals with resting coagulation parameters, while the second 
set focuses on stress-induced changes of coagulation parameters. Within each set, the effects 
of depression history and of chronic stress burden are examined independently, as well as 
their interacting effect.  
3.1. Hypotheses regarding basal coagulation 
3.1.1. The effects of remitted depression on basal coagulation 
Of the coagulation markers studied, fibrinogen stands out to have the strongest association 
with depression. Major depression has been associated with elevated resting levels of fibrino-
gen in a variety of studies (Martins-de-Souza et al., 2014; Wium-Andersen, Orsted, et al., 
2013) and increases in depressive symptoms and in fibrinogen levels were significantly corre-
lated in an examination of healthy school teachers over a 2-year period (Von Känel, 
Bellingrath, et al., 2009b).  
Another marker that has been extensively studied in relation to depression is PAI-1. A study 
by Eskandari et al. (2005) on premenopausal women with major depressive disorder (MDD) 
showed increased resting levels of PAI-1. Further, an independent association between high 
PAI-1 and long-term psychiatric symptoms in middle-aged men has been described by Huota-
ri et al. (2010). Lahlou-Laforet et al. (2006) report an elevated PAI-1 activity in depressed 
patients after adjusting for the presence of chronic heart disease, smoking, triglyceride con-
centration, hypertension and body mass index. In the current study we examine remitted de-
pression in relation to coagulation markers, which remains relatively unexplored. Baune et al. 
(2012) report that elevated PAI-1 levels were associated with remitted depression in a sample 
of elderly persons. Kling et al. (2007) examined CRP and amyloid A, which, like fibrinogen 
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belong to the family of acute-phase-proteins. Both these markers were significantly elevated 
in a sample of remitted depressed women compared to BMI-matched healthy controls. One 
can deduce that a pro-inflammatory state that has also been described elsewhere persists even 
after symptomatic recovery from depression (Kling et al., 2007). This suggests that fibrinogen 
may also be elevated in remitted depression. Accordingly, the following hypothesis is de-
duced: 
 
H1.1: Baseline fibrinogen and PAI-1 levels are higher in remitted depressed subjects com-
pared to controls. 
3.1.2. The effects of chronic stress on basal coagulation 
There are different concepts of what constitutes chronic stress. The two frequently discussed 
models regarding the workplace are the effort/reward imbalance model (Siegrist, 1996) and 
the demand/control/support model (Karasek & Theorell, 1990), also termed ‘job strain’. In the 
former, high demands at work are combined with low security and few career opportunities, 
while in the latter, the affected person experiences high psychological demands but at the 
same time has a low decision latitude or job control (Kivimäki et al., 2002).  
This combination of high demand and low control has been associated with increased cardio-
vascular mortality risk (Kivimäki et al., 2002) in a longitudinal study among employees who 
were free from cardiovascular disease at baseline The cardiovascular mortality was 2.2-fold. 
Further, job strain predicted future BMI and cholesterol concentrations. In persons with high 
job strain, caregivers, or persons suffering from PTSD, increases in the following hemostasis 
factors have been described: fibrinogen, D-Dimer, FVII, FVIII and VWF. Lower socioeco-
nomic status has been associated with higher resting plasma viscosity, VWF and Factor VIII 
(Steptoe, Kunz-Ebrecht, Rumley, & Lowe, 2003). A few studies have found that low socioec-
onomic status is associated with changes in fibrinogen, D-Dimer, FVII, FVIII and VWF. PAI-
1 increases at rest have also been associated with chronic stress in a range of studies 
(Eskandari et al., 2005; Huotari et al., 2010; Lahlou-Laforet et al., 2006; Mausbach et al., 
2007; Tsai, 2006). Furthermore, one study found that fibrinogen was elevated in unemployed 
persons (Kaptoge et al., 2007a). Based on these findings, the following hypothesis is derived:  
 
H1.2.: Subjects under chronic stress have elevated baseline levels of the procoagulant fac-
tors fibrinogen, DD, VWF and PAI-1 compared to controls. 
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3.1.3. The effects of the interaction between remitted depression and chronic stress on 
basal coagulation 
As seen in studies on Dexamethasone/CRH tests, major depression has been shown to have 
altered stress responsiveness, which is why it is often called a stress-related disease.  
So far, interaction effects between remitted depression and chronic stress on resting coagula-
tion levels have not been examined. The hypothesis is therefore a non-directional one.  
 
H1.3.: Baseline procoagulant markers in remitted major depression are altered, depending 
on the presence of chronic stress.  
 
The second part of this work looks at hemostatic responses to an acute stressor, the Trier So-
cial Stress Test (TSST). Again, the effects of remitted depression and chronic stress, as well 
as their combined effect are analyzed.  
3.2. Hypotheses regarding stress-induced coagulation 
3.2.1. The effects of remitted depression on stress-induced coagulation 
Regarding healthy subjects, previous research has described an increase in procoagulant fac-
tors with acute stress with the following markers showing significant increases: FVII, FVIII, 
FXII, fibrinogen, VWF antigen and platelets (Austin et al., 2011; Hjemdahl & Von Känel, 
2012; Thrall et al., 2007; Von Känel et al., 2013, 2001; Wirtz et al., 2008). For stress coagu-
lability in depressed individuals the literature is rather scarce. Neither of the studies examined 
includes major depression patients or remitted depressed patients (as diagnosed using the 
DSM-IV (Diagnostic and Statistical Manual of Mental Disorders). In a study similar to ours, 
which also used the TSST with healthy, middle-aged school teachers, increased levels of vital 
exhaustion and depression were associated with attenuated D-Dimer response to acute stress 
but with prolonged D-Dimer recovery (Von Känel, Bellingrath, et al., 2009a), indicating pro-
longed hypercoagulability after stress cessation.  
Another study found that depressive symptoms were associated with exaggerated D-Dimer 
increases after the TSST in elderly subjects (Von Känel, Dimsdale, et al., 2004). Taken to-
gether, the literature suggests that D-Dimer changes over time are affected by depressive 
mood. The following hypothesis is derived: 
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H2.1.: Remitted major depression has an effect on acute psychosocial stress (TSST)-
induced changes in D-Dimer levels.  
3.2.2. The effects of chronic stress on stress-induced coagulation 
Only few studies have examined how chronic stress influences reactions of the coagulation 
systems to an acute-stressor. Also, the way in which chronic stress was defined and assessed 
was not uniform. The results of a study on dementia caregivers showed that the number of 
negative life events experienced before a speech task was directly correlated with changes in a 
pro-coagulability score that included the thrombin/antithrombin III complex, D-Dimer, VWF, 
t-PA and PAI-1 (Von Känel, Dimsdale, Patterson, & Grant, 2003). Another study investigated 
social support with regards to stress-reactivity. Low levels of social support may also give rise 
to chronic stress. Wirtz et al. (2009), reported that high levels of social support, as assessed by 
a questionnaire, were associated with lower fibrinogen and D-Dimer before and after acute 
stress (TSST). Lower social support was associated with higher fibrinogen and D-Dimer lev-
els, both at baseline and following the stressor. These results were independent of BMI, age, 
and mean arterial blood pressure (Wirtz et al., 2009). Based on this research, it is hypothe-
sized that 
 
H2.2.: High chronic stress modulates procoagulant responses to acute psychosocial stress. 
3.2.3. The effects of the interaction between remitted depression and chronic stress on 
stress-induced coagulation 
Whether chronic stress (CS) and remitted major depression (MD) have a combined effect on 
stress-induced coagulation has so far not been examined in the literature.  
Since major depression is a stress-related disease, an interaction effect is likely. However, a 
non-directional hypothesis needs to be postulated: 
 
H2.3.: Whether MD+ and MD- differ in their procoagulant responses to acute stress de-
pends on the presence or absence of chronic stress. 
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4. Methods 
The experiment conducted for this study consisted of a preliminary interview of each partici-
pant that lasted approximately two hours, and an experimental assessment that took place dur-
ing an afternoon between 1pm and 5pm at the Max Planck Institute for Psychiatry, Munich. 
During the afternoon two psychosocial stress tests were carried out with each subject, of 
which only the first one is of relevance for this dissertation. Participants gave their written 
consent to take part in the study, which was approved by the local Ethics Committee of Mu-
nich’s Ludwig Maximilians University. Participants were also informed that they had the 
right to withdraw their consent at any time. A compensation of EUR 175 was paid for partici-
pation.  
4.1. Subject Sample 
A total of 63 subjects between the ages of 31 and 42 years took part in the study. Mean age 
was 35.22 years overall; 36.08 (SD: 3.57) years in the control group and 34.7 (SD: 3.48) years 
in the remitted depression group. The remitted depression group included 40 subjects, the 
control group 24 subjects. Four subjects in the depression group were taking antidepressant 
medication. There were 26 males, and 37 females, 13 of which were taking hormonal contra-
ception. Characteristics of the study sample are listed in Table 3 in the Results section. 
 
All subjects were recruited from the Early Developmental Stages of Psychopathology (EDSP) 
study, a prospective-longitudinal investigation that commenced in 1994. It was designed to 
investigate prevalence, incidence, risk factors, course of disease and comorbidity of mental 
disorders and includes a random sample of the city of Munich’s population register. In 1994, 
3021 participants between the ages of 14 and 24 were interviewed using the Munich- Compo-
site International Diagnostic Interviews (M-CIDI)(Wittchen & Pfister, 1997), which detects 
psychological disorders using DSM-IV. Between 1995 and 2005 participants were inter-
viewed using the M-CIDI at four different time points. (2005: N = 2210, response rate 73%. 
403 participants from the EDSP database were eligible for inclusion as potential participants. 
They were contacted and informed about the procedure. In case of approval to take part in the 
study, candidates underwent a screening interview via telephone to assess whether they were 
eligible for the study.  
In recruitment of subjects for the study, the aim was not to have a representative cross-section 
of the study cohort (EDSP) but to recruit an equal amount of subjects with and without a de-
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pression history. Subjects were therefore selected according to this information. During the 
experimental phase of the study, however, more subjects turned out to have suffered from 
depression, causing an imbalance between patient and control groups.  
 
At the time of the stress test, the hormonal system, the coagulation system and the immune 
system were not to be modified by influences other than the experimental stressor. Therefore 
the following exclusion criteria were defined for all subjects: 
- Hormonal disorders such as Morbus Cushing or Morbus Addison, untreated thyroid 
illnesses  
- A history of cardiovascular events such as myocardial infarction or stroke within the 
past 6 months  
- Organ transplant within the past 6 months 
- Treatment with cancer chemotherapy within the past 12 months 
- Chronic respiratory tract diseases 
- Autoimmune diseases 
- Diseases of the hematopoietic system or treatment with anticoagulant drugs 
- Glucocorticoid treatment or treatment with other pharmaceuticals that influence HPA-
axis functions 
- Pregnancy or breast-feeding 
- Professional athletes 
Further, persons were excluded who were diagnosed, at present or in the past, with the follow-
ing psychiatric disorders (DSM-IV): 
- Schizophrenia and other psychotic disorders  
- Social phobia 
- Substance-abuse  
- Needle-related anxiety 
- Bipolar affective disorder 
- Dysthymia  
Subjects in the remitted depressed group had been diagnosed with Major Depressive 
Disorder, according to DSM-IV, but were in remission for a minimum of six months at the 
time of the experiment. In the control group, all affective disorders, including generalized 
anxiety disorder, whether at present or in the past, were further exclusion criteria.  
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In case of acute infections/inflammation or an overseas flight within the past two weeks, the 
appointment for the experiment was postponed or the situation re-evaluated. The same was 
true for persons under high physical strain or suffering from symptoms of depression. Shift 
workers’ assessments were scheduled to take place on a day after a holiday or during a time 
of day shifts. Hormonal contraception and antidepressant medication were not among the ex-
clusion criteria. 35% of participating women were taking hormonal contraception. For female 
subjects who were not taking hormonal contraception, the day of the examination was chosen 
to coincide with the luteal phase of the monthly cycle (days 14-28), because sex differences in 
HPA-axis reactivity are known to be least during this time (Kirschbaum et al., 1999). Four 
subjects included in the analyses were taking antidepressant medication. All four were taking 
SSRIs: citalopram, escitalopram and paroxetine. To control for a potential influence of the 
antidepressant medication, the presence of such medication was included as a covariate in all 
analyses. Initially, 66 subjects were recruited. Two subjects were excluded from analyses due 
to depressive symptoms within the past six months prior to the examination day. One subject 
was excluded due to missing data for chronic stress. Therefore N = 63. Three subjects pre-
sented outliers for some of the coagulation parameters that were above or below two standard 
deviations from the mean. The respective values, but not the three subjects, were excluded for 
analysis.  
Groups  
In order to test for effects of remitted depression and chronic stress on coagulation factors, 
subjects were assigned to a MD+/- and CS+/- group, which resulted in a 2x2 design: 
 
MD+ MD- 
CS+ CS- CS+ CS- 
 
Remitted Major Depression (MD+) vs. healthy controls (MD-) 
Subjects were assigned to two groups with respect to their disease history. Subjects without 
history of any psychiatric disorders were defined as healthy control group (MD-, N = 24), 
while subjects with a lifetime history of major depression were assigned to the depression 
group (MD+, N = 39).  
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Participants in the MD+ group had to have a cumulative lifetime diagnosis of major depres-
sion (according to DSM-IV criteria as determined using the M-CIDI) and had been in remis-
sion for a period of at least six months at the time of examination. Group membership was 
determined using longitudinal data gained from regular M-CIDI-interviews.  
 
High chronic stress (CS+) vs. low chronic stress (CS -) 
Chronic stress in study participants was evaluated with the Trier Chronic Stress Inventory, 
TICS, (Schulz & Schlotz, 1999). Based on the total score of this questionnaire, the sample 
was split into two groups. Using the median split a group with high chronic stress and a group 
with low or no chronic stress was formed (CS+, N= 34; CS-, N=29). 
4.2. Experimental procedure 
Diagnostic assessment 
Participants of the EDSP study received a letter of invitation and were contacted by telephone 
to discuss their further involvement in the study. 
After giving their consent to participate and if inclusion criteria were fulfilled (as checked 
through an additional phone call), the eligible subjects were invited for a diagnostic assess-
ment. Here, the computerized Munich version of the Composite International Diagnostic In-
terview (M-CIDI) was used to assess symptoms and diagnoses of DSM-IV disorders and their 
onset, duration and severity (Wittchen & Pfister, 1997) . The same interview had been used at 
all assessments during the EDSP study. A variety of other questionnaires were completed at 
this assessment, some of which are described further on.  
Trained interviewers conducted the interval version of the M-CIDI covering the time period 
between the previous assessment and the current evaluation.  
Beck’s Depression Inventory II (BDI-II) was used to exclude the presence of acute symptoms 
of depression within the last 14 days. Participants received an invitation for the experimental 
part of the study if their BDI-II score was at or below 14.  
Setting 
The experiments took place in the sleep laboratory at the Max Planck Institute, which proved 
to be a good choice since it shielded the participants from outside disturbances. A principal 
investigator and a lab technician were present. A detailed protocol regarding instructions for 
the study participants, a schedule for blood collections and questionnaires was established so 
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that the conditions were as similar as possible for each study subject. The study protocol is 
presented in Table 2. 
The subjects were invited to arrive at the institute with enough time to minimize stress and get 
used to the new surroundings. There was also enough time for the stress caused by placing a 
venous catheter to subside before beginning the actual experiments.  
Trier Social Stress Test (TSST) 
As it was our priority to carry out the experiments in a most accurate and standardized manner, 
a detailed protocol was prepared as part of the study design so that conditions were the same 
for all participants (see Table 2). It listed in great detail the steps that the investigator and 
technical assistants were to go through during the afternoon. Instructions for the test subjects 
regarding the TSST were read out loud to minimize inconsistencies and ambiguities due to the 
investigator’s interaction with the test subjects.  
For the induction of acute stress we used the Trier Social Stress Test (TSST), a standardized 
experimental protocol developed by Kirschbaum et al. (1993). In the course of the test after-
noon, the TSST was used twice, but for coagulation parameters only the first TSST was rele-
vant. Several blood tests were performed for measurement of coagulation parameters.   
In a first instruction 40 minutes prior to the TSST, subjects were informed that they were to 
take part in a psychosocial stress test that consists of two tasks to be performed in front of a 
jury. They were told that they first had to hold a speech that was to be videotaped and record-
ed. The material would then be used in an analysis of language and behaviour. The subjects 
were told to present themselves in the most convincing manner possible, so as to receive a 
good evaluation.  
In a second instruction 25 minutes before the TSST, subjects were informed that their specific 
task during the stress test was to give a presentation for a job application or for a promotion. 
The subjects were able to choose the field this job was in, however, it was pointed out to them 
to choose a realistic job that could fit into their current lives. Within this 5-minute talk, the 
subjects would have to convince the audience of their suitability for this job/promotion. They 
would have to make sure to be within the video-camera’s range. The jury could interrupt and 
ask further questions if needed. During this second instruction, the participants were informed 
that after their talk they would have perform a second task, and that they would receive in-
structions then. Between the first and second instruction for the TSST, participants had to do a 
computerized neuropsychological test (Stroop color-word conflict test) measuring attention 
and concentration. Participants were informed that their results on this test would be taken 
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into consideration for a final evaluation. In this work, however, performance on the Stroop 
test was not analyzed and served as another stressful element. 
After a 10-minute preparation time, subjects were led to a different room in which the jury 
was waiting for them. They were not allowed to take their written notes along.  
The room was equipped with a video camera connected to a screen in which the subjects 
could see themselves. A microphone was handed to them at the beginning of their speech.  
The jury consisted of two persons wearing laboratory coats. They were not to give any feed-
back or reassurance and had to keep neutral facial expressions.  
Upon arrival of the participant, the video camera was switched on. After handing the micro-
phone to the participant, the jury leader asked the participant to start the speech and started a 
stopwatch.  
Five minutes into the speech the jury interrupted the participant and gave instructions on the 
second task, a mental arithmetic task. In steps of 13, the participant was asked to subtract 
from 1678 in their fastest and most accurate manner. Should participants make a mistake, they 
had to start over at 1678. After this second task the participants were lead to the previous 
room where they were allowed to read a magazine or newspaper.  
4.3. Assessment of the stress response  
Heart rate as a response of the sympathetic nervous system or SAM-axis was measured using 
a pulse measurement belt (Polar© RS400) that participants placed around their chest. It 
transmitted heart rate to a pulse watch that was worn around the wrist.  
To test for responses in the HPA-axis, cortisol levels were measured. 
Blood for cortisol measures was collected at six times during the test afternoon: at baseline, 
directly before the TSST, directly after, and +15, +30 and +45 minutes after the TSST. 5ml 
EDTA aliquots were used, centrifuged at 4000x/min, their supernatant (approximately 1ml) 
separated and frozen at -20°C until further analyses were carried out using a radioimmunoas-
say kit (CT Cortisol RIA, DRG Diagnostics, Marburg, Germany) This kit has a detection limit 
at 1.7 ng ⁄mL. 
Multidimensional adjectives questionnaire (BSKE) regarding current state 
At seven different time points subjects completed the short form of the multidimensional  
adjectives questionnaire (BSKE). This test examines subjects’ current mental state using a 
likert-scale from 1 (= not at all) to 6 (= agree fully) and examines, among other categories, 
anxiety and inner restlessness (Janke, Debus, Erdmann, & Hüppe, 1995). The 12-item form 
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was used at several time points during the test afternoon: directly before the TSST instruc-
tions, directly before the TSST, after the TSST (retrospectively regarding the TSST) and three 
times during the recovery period after the TSST. The participants’ subjective reactions to the 
stressor, i.e. anxiety and inner restlessness, were considered for statistical analyses.  
4.4. Sampling procedure and laboratory analyses  
At the beginning of the experiment, the principal investigator or medical student placed a ve-
nous catheter in the subjects’ forearm. This catheter was connected to a flexible tube system, 
which connected through the wall to the lab technician’s bench. After each collection, the 
tube was flushed with 10ml 0.9% sodium chloride to prevent clotting. Between blood collec-
tions, the subject received a 0.9%-sodium-chloride drip (50ml/h, Secura Infusomat, B-Braun, 
Melsungen) in order for the catheter to remain permeable. As participants were lead to the 
other room for the TSST, the tube was removed and a stylet was placed to clog the catheter. 
Routine blood samples were taken twice during the afternoon and included count of leuko-
cytes, erythrocytes and thrombocytes, hematocrit and hemoglobin, MCV and MCH liver en-
zymes and creatinine. One 2.5ml EDTA tube and one 7.5ml serum tubes were drawn (Mono-
vetten Sarstedt, Nürnberg). The EDTA tube was centrifuged at 4000x/min for 7  
minutes and its supernatant separated and stored at +4°C until further analyses at the institute 
for clinical chemistry. A urine sample was taken to exclude drug use (benzodiazepines, opi-
oids, cannabis). 
 
Measurements of coagulation parameters took place at rest, 15 min post-stress and 45 min 
post-stress. PAI-1 was measured at rest only. For the final 22 subjects of the examination rou-
tine we decided to add another time point for blood collection for additional analyses: directly 
post-stress. Table 2 shows the exact time points in which blood samples for coagulation anal-
yses were obtained.  
2x 3ml venous blood was collected into 0.3ml citrate buffer tubes (Monovetten Sarstedt,  
Nuremberg). Aliquots were centrifuged at 4000x/min and the plasma containing the clotting 
factors was separated, then kept at +4°C temperature, and frozen at -20°C until they were 
shipped to a laboratory in Switzerland for further analysis. For the transport-78°C dry ice was 
used. Fibrinogen, vWF and PAI-1 levels were measured using a multiplexed particle-based 
flow cytometric cytokine assay (Vignali, 2000). Assay kits were used from Millipore (Zug, 
Switzerland) and R&D Systems (Oxon, UK). The analysis was conducted with a conventional 
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flow cytometer (Guava EasyCyte Plus, Millipore, Zug, Switzerland). For D-Dimer measures, 
an ELISA from Technoclone (Vienna, Austria) was used. Further 2x 7.5ml blood was drawn 
into DNA-aliquots (Monovette Sarstedt K3E) for other analyses. In addition, RNA aliquots 
for 2.5ml whole blood were drawn, pivoted and kept at room temperature until they were fro-
zen at -20°C on the next day. RNA was analyzed for the study of polymorphisms in the 
FKBP5 gene and its association with major depression. 
4.5. Questionnaires 
Before the study day, either at home or the morning before, the subjects were asked to fill out 
the Munich version of the Composite International Diagnostic Interview questionnaire (M-
CIDI), a questionnaire regarding symptoms, syndromes and diagnoses of DSM-IV disorders 
(Wittchen & Pfister, 1997). The same interview was used in the longitudinal EDSP study at 
all assessments. Trained interviewers conducted the interval version of the M-CIDI covering 
the time period between the previous assessment and the current evaluation. 
Beck Depression Inventory (BDI-II) 
During the diagnostic appointment, the BDI-II (Beck & Steer 1996; German version by 
Hautzinger et al. 2006) was used to assess the presence and severity of acute depression 
symptoms within the last 14 days. There are 21 items including questions on sadness, feelings 
of guilt, loss of energy and appetite that the participant answers on a scale from 1-4 points, 
which are added to yield the total score. 0-13 points are considered as minimal, 14-19 point as 
mild, 20-28 as moderate and 29-63 points as severe depression. Participants received an invi-
tation for the experimental part of the study if their total score was below 14. The BDI-II 
questionnaire was also filled out a second time on the test day before the stress protocol. 
Trier inventory for the assessment of chronic stress (TICS) 
This 57-item questionnaire developed by Schulz and Schlotz (1999) evaluates the following 
dimensions of chronic stress: work overload, pressure to succeed, excessive demand at the 
workplace, work discontent, social tension, lack of social recognition, social stress. A 12-item 
screening scale (SCSS) serves as a comprehensive measure of chronic stress. Internal con-
sistency (Cronbach's Alpha) of this scale has been reported at α = .87, indicating good to very 
good reliability (Petrowski, Paul, Albani, & Brähler, 2012).  
The frequency by which stress events were experienced or stressful feelings were perceived in 
these areas over the past three months, from 0 (never) to 4 (very often), permits the investiga-
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tor to estimate the subjects’ level of stress chronicity. Examples for questions found in the 
TICS questionnaire are listed in Table 1. In the present study the questionnaire was completed 
during the diagnostic interview.  
Table 1. Examples of questions asked in the Trier inventory for the assessment of chronic stress for each 
category, as found in Petrowski, Paul, Albani, & Brähler (2012).  
Category Example question 
Work Overload “I have too many tasks to perform. ” 
Social Overload “I must frequently care for the well-being of others. ” 
Pressure to Perform “I have tasks to fulfill that pressure me to prove myself. ” 
Work Discontent “Times when none of my tasks seem meaningful to me.” 
Excessive Demands at Work “Although I try, I do not fulfill my duties as I should” 
Lack of Social Recognition “Although I do my best, my work is not appreciated” 
Social Tensions “I have unnecessary conflicts with others.” 
Social Isolation “Times when I have too little contact with other people. ” 
Chronic Worrying “Times when I worry a lot and cannot stop.” 
 
Table 2. The study protocol used for the examination. Overview of time points and tasks of investigator 
and technical assistant. 
Time Main investigator 
 
 
Technical assis-
tant 
 
Participant (P) 
Questionnaires Blood collection 
13:15    Urine sample 
Pulse-meter on 
Welcome P at 
lobby 
13:30  BDI-II  Routine blood work 1 
 
 - Instruction 
- Placement of 
venous cathe-
ter  
- P can read 
newspaper or 
book 
13:55     Practice run 
Emotional Stroop 
14:00 Baseline 1. BSKE 1. Blood collection 
RNA, Plasma, Cyto-
kines, Coagulation 
parameters, Cortisol 
Heart rate ___ 
 
 
14:05     - Instruction I 
for TSST 
- Emotional 
Stroop 
14:15  2. BSKE  Heart rate ___   
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14:18     - Instruction II 
for TSST 
- 10 min prepa-
ration for 
TSST 
14:30 0 min pre stress 3. BSKE 2. Blood collection 
RNA, Plasma, Cortisol 
Heart rate ___   
Time on pulse 
watch ___ (Pre-
TSST) 
 
14:35    Disconnect partic-
ipant from blood 
collection 
TSST: take P to 
other room, 
TSST from 
14.35 to 14.50 
14:50 0 min post stress  
4. BSKE-
retrospectively 
3.  Blood collection 
Coagulation parame-
ters (n=22), Cortisol 
Heart rate ___   
Time on pulse 
watch ___ (Post-
TSST) 
 
     Switch on movie  
15:05 15 min post stress 5. BSKE 4.  Blood collection 
Coagulation parame-
ters, Cortisol 
Heart rate ___    
15:20 30 min post stress 6. BSKE 5.  Blood collection 
RNA, Plasma, Cortisol 
Heart rate ___    
15:35 
END of 
experiment 
45 min post stress 7. BSKE 6.  Blood collection 
Routine blood work 2 
Coagulation parame-
ters, Cortisol 
Heart rate ___    
 
 
 
Switch off movie 
4.6. Statistical analyses  
Data were analyzed using PASW Statistics for Windows (Version 18.0., SPSS Inc., released 
2009, Chicago, IL, USA). 
For statistical analyses of variables the level of significance was set at 5% (two-tailed). Group 
differences with a p-value of less than .10 are reported as suggestive trends. 
Demographics 
Differences between groups in quantitative and categorical demographic variables were eval-
uated with analyses of variance or Chi²-Tests, respectively. The presence of group interaction 
effects between the categorical variables was analyzed using a log-linear model.  
Stress induction: effects of the TSST stress paradigm 
To determine whether the stress task was effective, we compared the pre- and (maximum of 
the) post-stress measure of heart rate, cortisol and subjective arousal and anxiety (BSKE sub-
scores ‘inner restlessness’, ‘anxiety’) in a repeated 3 way measures ANCOVA including two 
independent factors, MD and CS, and the respective baseline value as covariate. To localize 
the source of potential repeated measures effects, simple contrasts to the first assessment are 
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reported. To assess whether the TSST caused any overall effect on the three coagulation pa-
rameters, paired samples t-test were used for baseline and post-stress measures of all subjects.  
Baseline effects on coagulation parameters 
To examine the effect of depression and chronic stress on the levels of the coagulation factors 
PAI-1, Fibrinogen, DD and VWF at baseline, a two-factorial ANCOVA with the independent 
factors MD and CS was used. Age, gender, hormonal contraception, smoking status, antide-
pressant medication, hematocrit, hemoglobin, thrombocytes, leukocytes, CRP and smoking 
status were included as covariates. Smoking status was defined as consumption of >=5 ciga-
rettes per day.  
Stress effects over different time points 
To examine the effect of depression and chronic stress on the levels of the coagulation factors 
at the different time points (resting state, 15 minutes post-stress, 45 minutes post-stress) a 
repeated measures ANCOVA with two independent factors, MD and CS was used. Age, gen-
der, hormonal contraception, antidepressant medication, smoking status, hematocrit,  
hemoglobin, thrombocytes, leukocytes and CRP were included as covariates. The Green-
house-Geiser correction of degrees of freedom was applied to account for violations of the 
sphericity assumptions. For identifying the source of a potential repeated measures effect, 
simple contrasts to baseline were calculated. 
Separate repeated measures ANCOVAs with the factor MD and CS, respectively, were used 
to examine separately the effects of depression and chronic stress on coagulation markers 
directly post-stress (N=22). 
Due to the small sample size for the measurement of coagulation markers directly following 
the stressor, the 2x2 design would have created groups with too few members. Therefore MD 
and CS were evaluated separately and not their interaction in the N=22 subsample.  
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Associations of current depressive symptoms and chronic stress scores with coagulation 
factor levels  
Partial correlation analyses were carried out to search for associations of the scores on the 
Beck depression inventory (BDI-II) and on the screening scale and subscales of the chronic 
stress questionnaire (TICS) with coagulation factor levels, correcting for the respective other 
group variable (CS for BDI-II associations, and MD for TICS associations).  
 
Sensitivity Analysis 
A sensitivity analysis was conducted using G*Power v. 3.1 (Faul et al., 2009) with alpha and 
beta errors set to .05 and .20, respectively. Given the sample size of N=63 and the 2 x 2  
factorial design with repeated measures (resting state, 15 min post stress, 45 min post stress, 
assuming a moderate correlation of r = .5 between repeated measures), we calculated a detect-
able effect size of f = .19. Thus, the detectable effect size of our analysis ranges between the 
boarders of a small (f = .10) and medium effect (f = .25) according to the effect size conven-
tions reported by Cohen (1988).   
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5. Results 
Source data for all Figures presented in this section can be found in Appendix I. 
5.1. Demographics 
The demographic characteristics of the study participants are listed in Table 3. Remitted de-
pressed and control subjects did not differ with respect to age, gender, BMI, years of educa-
tion (primary and secondary education), relationship status, antidepressant treatment, age at 
onset of first depression episode, hormonal contraception (% of females) and BMI score on 
the test day.  
Subjects with high CS compared to low CS, as determined using the 12-item screening scale 
of the TICS questionnaire (Trier inventory of chronic stress) did not differ significantly with 
respect to age, gender, BMI and years of education. On average, subjects had between 1 and 
38 points on the TICS questionnaire with a mean of 12 (+8.6) points, with 48 being the max-
imum number of points.  
Persons with MD and CS together did not differ from the control group with respect to the 
abovementioned characteristics.  
Regarding relationship status, it is noteworthy that single persons were more often chronically 
stressed than married persons (p=.006).  
On the BDI-II, subjects had between 0 and 14 points with an average of 2.0 (+3.0) points. No 
difference was found between subjects in the depression group and controls. 
However, chronically stressed subjects had significant higher BDI-II scores than controls, 
with mean scores at 3.2 (+3.7) versus .6 (+.8); p=.001. 
Chronically stressed individuals scored higher on the Beck Depression Inventory (BDI-II) on 
the test day (p=.001) than did individuals with low chronic stress. Subjects in the MD+ group 
had higher chronic stress scores than MD- subjects (p=.007).  
Since smoking is known to increase the risk for deep vein thrombosis, it was taken as a co-
variate in all analyses. Smoking status was defined as >=5 cigarettes per day. Out of the 63 
subjects, 12 fell into this category, with a consumption of a minimum of 5 to a maximum of 
20 cigarettes per day. In none of the analyses of covariance smoking status affected the re-
sults. 
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Table 3. Demographic characteristics of the study participants. CS+: chronic stress, MD+: major depres-
sion. CS-, MD- negative for chronic stress and major depression. ANOVA and Chi²-Tests were calculated 
for group comparison in quantitative and qualitative variables, respectively. SSRI-antidepressant treat-
ment: selective-serotonine-reuptake-inhibitor, (N=4): escitalopram, citalopram, paroxetine. 
 MD+ 
N=39 
MD- 
N=24 
P values (ANOVA / 
Chi²) 
Variable (n) % CS+ (20) 
51.3 
CS- (19) 
48.7 
CS+(14) 
58.3 
CS- (10) 
41.7 
MD CS MD x 
CS 
Age in years 
(SD) 
34.5 (3.5) 35.0 (3.5) 36.1 (4.0) 36.1 (3.1) .159 .779 .802 
Female (%) 14 (60.9) 9 (39.1) 9 (64.3) 5 (35.7) .948 .120 .802 
Years of Edu-
cation (SD) 
12.1 (1.9) 11.9 (1.5) 12.2 (1.8) 12.8 (1.5) .272 .719 .408 
BMI (SD) 24.5 (3.2) 23.5 (2.4) 24.0 (2.8) 24.7 (5.0) .664 .876 .330 
Relationship 
status n (%) 
  Single 
  Married 
  Divorced 
 
 
12 (60) 
4 (26.7) 
4 (100) 
 
 
8 (40) 
11 (73.3) 
- 
 
 
8 (72.7) 
5 (41.7) 
1 (100) 
 
 
3 (27.3) 
7 (58.3) 
- 
 
 
.511 
 
 
 
.006 
 
 
.415 
Depression 
history 
Antidepressant 
treatment 
(SSRI) n (%) 
 
Age at onset, 
years (SD) 
 
 
1 (5.0) 
 
 
19.1 (4.1) 
 
 
1 (5.3) 
 
 
19.3 (4.9) 
 
 
2 (14.3) 
 
 
0 (0) 
 
 
.594 
 
 
.383 
 
 
.975 
Hormonal 
contraception 
n (% female) 
3 (21.4) 4 (44.4) 4 (44.4) 2 (40.0) .443 .443 .436 
Amount 
Smokers (%) 
3 (15) 4 (21) 4 (29) 1 (10) .936 .736 .552 
BDI-II score 
on test day 
(SD) 
3.3 (5.5) .7 (.8) 3.1 (4.1) .5 (.7) .794 .001 .974 
TICS screen 
(SD) 
20.2 (8.7) 6.9 (2.4) 14.5 (6.1) 3.9 (2.0) .007 <.001 .394 
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5.2. Resting coagulation parameters 
5.2.1. Fibrinogen 
The remitted depression group and control group differed significantly in baseline levels of 
fibrinogen as shown in Figure 4 (left). Members of the remitted depression group had higher 
fibrinogen levels at baseline: 111.19 mg/dl in the control group versus 126.74 mg/dl, in the 
remitted depression group, which equals a difference of 12% (F1,50=7.738, p=.008). There was 
no effect of CS (F1,50=.139, p=.711) or of the interaction of CS and MD (F1,50=.184, p=.670) 
on baseline levels of fibrinogen.  
Figure 4. Mean baseline concentrations of fibrinogen. A) Comparison between subjects with remitted 
depression and without a history of depression. B) Comparison between subjects with and without chronic 
stress. **: p<.01, n.s.: non-significant.  
5.2.2. D-Dimer 
The remitted depression and control group showed no significant differences in baseline lev-
els of D-Dimer (F1,48=.209, p=.649). Subjects with chronic stress showed baseline D-Dimer 
concentrations that were on average 45% higher than in those without chronic stress.  
Although this difference was not significant (F1,48=2.96, p=.092), this can be seen as a sugges-
tive trend toward higher resting D-Dimer levels in chronically stressed subjects (see Figure 5). 
No interaction effect of MD and CS was observed (F1,48=2.570, p=.115).  
0
20
40
60
80
100
120
140
Fibrinogen (mg/dl)
MD-
MD+
0
20
40
60
80
100
120
140
Fibrinogen (mg/dl)
CS-
CS+
* * n.s.
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Figure 5. Mean baseline concentrations of D-Dimer. Left: comparison between subjects with remitted 
depression and without a history of depression.  Right: comparison between subjects with and without 
chronic stress. Depicted are means and standard error bars. (*): p<.10, n.s.: non-significant. 
5.2.3. VWF 
No significant differences in resting levels of VWF were found between the MD and control 
group (F1,49=.203, p=.654), as well as between subjects with chronic stress and without chron-
ic stress (F1,49=.450, p=.505). See Figure 6. An interaction effect of MD and CS cannot be 
reported (F1,49=.626, p=.432). 
 
 
Figure 6. Mean baseline concentrations of VWF. Left: comparison between subjects with remitted depres-
sion and without a history of depression. Right: comparison between subjects with and without chronic 
stress. Depicted are means and standard error bars. n.s.: non-significant. 
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5.2.4. PAI-1 
PAI-1 resting levels were neither significantly different between remitted depressed subjects 
and controls (F1,50 =.246, p=.622) nor between chronically stressed subjects and controls 
(F1,50=.837, p=.365), as Figure 7 shows. There were no interaction effects of MD and CS in 
the abovementioned analyses of hemostasis factors (F1,50=.308, p=.581). 
 
 
Figure 7. Mean baseline concentrations of PAI-1. A) Comparison between subjects with remitted depres-
sion and without a history of depression. B) Comparison between subjects with and without chronic 
stress.  Depicted are means and standard errors. n.s.: non-significant. 
5.3. Stress induction: effects of the TSST paradigm 
The TSST psychosocial stress protocol elicited an effective stress reaction in all four study 
groups, as seen in heart rate, as a measure of SAM-axis activity, and in cortisol increases, as a 
sign of HPA-axis induction. 
5.3.1. Heart rate response 
Heart rate increased from an average at baseline of 80.26 beats per minute to an average of 
98.13 beats per minute at the beginning of the TSST and 100.06/min at the end of the TSST.  
The general linear model revealed a non-significant change over all heart-rate measures with 
correction for baseline differences (F4,200 =1.679, p=.159). However, a significant stress effect 
could be seen for the pre-to post-TSST heart rate (F1,52=7.218, p=.01) and for the heart rate 
pre-TSST to +30 min (F1,52=4.123, p =.047). No significant effect of depression history 
(F1,52=3.179, p=.080), chronic stress (F1,52=.581, p=.449) or their interaction (F<.001, p=.988) 
was found. Heart rate curves for all four groups are depicted in Figure 8. 
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Figure 8. Mean heart rate measures of the four groups MD+CS, MD, CS and MD-CS-  
before and after the TSST. The figure shows means and standard errors corrected for 
baseline differences.  
5.3.2. Cortisol response 
On average, the TSST had a significant effect on cortisol levels (F2.2, 123.1=15.5, p<.001), as 
shown in Figure 9. This effect was not due to group membership, that is, membership to one 
of the following: MD+CS+, MD+CS-, MD-CS+ and MD-CS-.  
An increase of cortisol levels from 127.1 ng/ml at rest to 150.8 ng/ml right after the stress test 
was measured, equalling an increase of 15.7%. 
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Figure 9. Cortisol response curves separate for each of the four groups. MD+: major depression.  
CS+: chronic stress. The figure shows means and standard errors corrected for baseline differences.  
5.3.3. Perceived stress 
The TSST evoked a noticeable change in the subjects’ feelings of perceived stress. The sub-
score ‘inner restlessness’ as measured by the BSKE questionnaire increased significantly 
from baseline to the stressor (F3.6, 198.8=55.208, p<.001); see Figure 10. Group effects (MD, 
CS, CS x MD) were not observed.  
Subjects also perceived their anxiety levels, as measured using the BSKE ‘anxiety’ subscore, 
to rise with the stressor task (F2.4, 133.6=25.666, p<.001) as shown in Figure 10. Again, group 
effects were not detected. 
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Figure 10. Changes in perceived anxiety during the stress protocol, as measured using the BSKE ques-
tionnaire. A: inner restlessness subscore. B: anxiety subscore. The figure depicts estimated means and 
standard errors corrected for baseline differences.  
5.4. Stress-induced coagulation changes 
Figure 11 gives an overview of the descriptive changes observed over the time points for the 
three markers (fibrinogen, D-Dimer and VWF), independent of group, with N=63. None of 
the changes between pre-and post-stress reached si gnificance, however, for D-Dimer and 
VWF trends were observed (p=.054 and p=.057, respectively).  
 
Figure 11.  
Changes in the three 
coagulation parameters 
in response to the TSST 
(N=63), independent of 
group. The figure de-
picts means and stand-
ard errors for all sub-
jects.  
A: Fibrinogen changes 
over time 
B: D-Dimer changes 
over time 
C: VWF changes over 
time  
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5.4.1. Fibrinogen 
On a purely descriptive level, overall fibrinogen levels decreased from 120.8 mg/dl (+26.2) at 
baseline to 116.2 mg/dl (+31.8) post-stress, and at +45 minutes decreased to 115.8 mg/dl 
(+30.1); see Fig. 11A. 
Multivariate analyses revealed that the psychosocial stress induced by the TSST caused a sig-
nificant change in fibrinogen levels (F1.9,94.2=4.076 p=.021) over time, more precisely from 
baseline to 15 min post-TSST to 45 min post-TSST. Depression history accounts for this 
overall significant effect of TSST on fibrinogen levels (F1,49=7.850, p=.007).  
Chronic stress does not significantly account for the effect of TSST on fibrinogen levels 
(F1,49=.052, p=.820). The interaction of chronic stress and depression did not have an effect 
on fibrinogen either (F1,49 =.000, p=.993). 
When considering baseline fibrinogen levels and the fibrinogen levels measured immediately 
after the TSST, the effect of TSST on the fibrinogen reaction was non-significant 
(F1,10<=.453, p>=.516) although the previously observed depression effect remains 
(F1,10=6.042, p=.034); see Figure 13. The effect of chronic stress, however, was not  
significant (F1,10 =.506, p=.493). As mentioned earlier, interaction effects were not calculated 
due to small group sizes in the comparison of baseline to directly post-TSST. 
 
Figure 12. Baseline to post-stress measures of fibrinogen in the four groups. Presented are means with 
standard errors. +positive, -negative for MD: major depression, CS: chronic stress.  
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Figure 13. Baseline to post-stress measures of fibrinogen, including another post-stress time point (imme-
diately post-TSST). Left: by MD: depression history. Right: by CS: chronic stress. Depicted are means 
and standard errors.  
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5.4.2. D-Dimer 
A trend toward a change in D-Dimer levels was observed during the TSST. Average D-Dimer 
levels of all subjects increased from 56.6 ng/ml (+85.6) at baseline to 79ng/ml (+93.7) ng/ml 
at 15 min (p=.054). 45 minutes following the TSST they had decreased again to 53ng/ml 
(+82.7). The difference between baseline and 45 minutes post-TSST was not significant 
(p=.633), see Fig. 11B. 
In terms of repeated measures, the psychosocial stress test did not affect D-Dimer levels since 
the overall effect of the stressor was not significant (F1.6,76.6=.099, p=.868). Depression did not 
have an effect on D-Dimer levels (F1,47=.008 p=.930). Chronic stress however, had a signifi-
cant effect (F1,47 =4.107 p=.048), and a trend can be observed regarding the interaction of 
chronic stress and a history of depression (F1,47=3.880 p=.055) on D-Dimer levels. As Figure 
14 shows, D-Dimer levels rose in all subjects after the TSST, but the increase was most pro-
nounced when chronic stress was present, i.e. in the MD-CS+ group (increase by 38%) and 
the MD+CS+ group (increase by 25%). For repeated measures in the baseline to directly post-
stress with the smaller sample of N=22, the TSST again did not seem to affect stress-
coagulability (F1,10 <=1.617, p>=.232). There was also no effect of depression history 
(F1,10=2.560, p =.141) on D-Dimer levels. The CS effect seen for the larger sample could not 
be reproduced in the smaller sample over the two tested time points (F1,10 =2.627, p=.136).  
 
Figure 14. Baseline to post-stress measures of D-Dimer in the four groups. Depicted are means with 
standard errors. MD: major depression, CS: chronic stress.  
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Figure 15. Baseline to post-stress measures of D-Dimer. including another post-stress time point (immedi-
ately post-TSST). Left: by MD: depression history. Right: by CS: chronic stress. Depicted are means and 
standard errors. 
  
5.4.3. VWF 
In all subjects, plasma levels of VWF increased on average from 11.80 mg/L (± 5.32) at rest 
to 13.16 mg/L (± 4.81) 15 minutes post-stress. While this difference did not reach signifi-
cance (p=.057), it suggests a trend. After 45 minutes, average levels increased again to 13.25 
mg/L (± 4.23). The difference between baseline and the recovery measurement 45 minutes 
after the stressor reached significance (11.80 mg/L to 13.25 mg/L p=.026); see Fig. 11C. 
Repeated measures revealed, however, that the psychosocial stressor did not affect VWF  
levels significantly (F1.5,70.9=1.643, p=.205) and that neither the presence of depression history 
(F1,48=.724, p=.399) nor chronic stress (F1,48=.302, p=.585) were significant. 
Interaction effects were also not significant (F1,48=.048, p=.828). 
The same was observed for the baseline to immediate post-TSST measures (N=22). Neither 
the effect of TSST (F1,9<=1.722 p>=.222), nor the effect of depression (F1,9=.603, p=.457) nor 
the effect of chronic stress (F1,9=.281, p =.609) were significant. 
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Figure 16. Baseline to post-stress measures of VWF. Presented are means plus standard errors, separate 
for the four groups. +positive, -negative for MD: major depression, CS: chronic stress.  
 
 
 
 
Figure 17. Baseline to post-stress measures of VWF, including another time point (immediately post-
TSST). Left: by MD: depression history. Right: by CS: chronic stress. Depicted are means and standard 
errors.  
5.5. Associations between depression symptoms and chronic stress load, and 
hemostatic markers 
Partial correlation analyses were carried out to additionally examine the effects of depression 
symptoms and different aspects of chronic stress on hemostatic parameters. The same covari-
ates as in the ANCOVA analyses were used plus CS or MD to further control for the respec-
tive other group effects (CS for depression symptoms, MD for chronic stress load).  
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Coagulation parameters and depression symptoms 
Partial correlation analyses between fibrinogen, D-Dimer, VWF, PAI-1 levels and the scores 
on Beck’s Depression Inventory II at the test day did not reveal any significant associations. 
The results of this correlation analysis are listed in the appendix. 
Coagulation parameters and chronic stress  
Associations between the TICS screening score and the nine subscores are listed in Table 5. 
Fibrinogen levels directly post-stress correlated negatively with overall stress (r=-.682, 
p=.030) and positively with the TICS subscore chronic worrying (r=.811, p=.004). 
Fibrinogen levels at 15 minutes post-stress showed a weak negative correlation with the sub-
score ‘Excessive demand at the workplace’ (r= -.297, p= .038) and ‘Social tensions’ (r=-.279, 
p=.050).  
D-Dimers measured directly post-stress correlated positively with TICS’ section ‘pressure to 
succeed’ (r=.637, p=.047). 
As for PAI-1 levels and overall chronic stress, a negative association was discovered, albeit 
only a weak one (r=-.246) and as a trend, i.e. non-significant (p=.082). The subscore ‘social 
tensions’ showed a weak negative correlation with PAI-1 (r=-.313, p=.025). 
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Table 5. Pearson’s correlation coefficients for correlations between hemostatic measurements and TICS 
scores. The TICS consists of nine subscores and one screening score for overall measurement of chronic 
stress load. ‘post-stress’ stands for measurements that were taken immediately following the TSST and 
 ‘+15 min’ for those taken 15 minutes after the TSST. 
 TICS 
screening 
score 
TICS  
Work 
overload 
TICS  
social 
overload  
 
TICS  
pressure 
to per-
form 
TICS  
work 
discon-
tent 
TICS  
Excessive 
demand 
at work-
place 
TICS 
Lack of 
social 
recogni-
tion 
TICS 
social 
tensions 
 
TICS  
social 
isolation 
TICS  
chronic 
worrying  
Fibrinogen 
baseline 
-.152 
(p=.286) 
-.048 
(p=.739) 
-.058 
(p=.688) 
-.117 
(p=.418) 
-.164 
(p=.249) 
-.136 
(p=.249) 
-.264 
(p=.061) 
-.168 
(p=.239) 
-.188 
(p=.186) 
-.167 
(p=.241) 
Fibrinogen 
(N=22) 
post-stress 
-.682 
(p=.030) 
-.618 
(p =.057) 
.034 
(p =.927) 
.270 
(p =.450) 
-.601 
(p=.066) 
-.409 
(p=.275) 
-.256 
(p=.475) 
-.261 
(p =.467) 
-.278 
(p=.436) 
-.811 
(p=.004) 
Fibrinogen 
(N=63) 
+15 min 
-.257 
(p= .072) 
-.121 
(p=.399) 
.033 
(p=.821) 
-.093 
(p=.525) 
-.270 
(p=.058) 
-.297 
(p=.038) 
-.268 
(p=.060) 
-.279 
(p=.050) 
-.149 
(p=.301) 
-.231 
(p=.106) 
D-Dimer 
baseline 
.073 
(p=.616) 
.065 
(p=.659) 
.190 
(p=.191) 
.176 
(p=.230) 
-.017 
(p=.906) 
.059 
(p=.693) 
.204 
(p=.159) 
.175 
(p=.229) 
-.009 
(p=.950) 
.056 
(p=.702) 
D-Dimer 
(N=22) 
post-stress  
.443 
(p=.199) 
.337 
(p =.341) 
.399 
(p= .253) 
.637 
(p=.047) 
.193 
(p=.593) 
.612 
(p=.080) 
.352 
(p =.318) 
.341 
(p=.335) 
.058 
(p=.873) 
.433 
p=.211) 
D-Dimer 
(N=63) 
+15 min 
.103 
(p =.488) 
.168 
(p=.253) 
 
-.004 
(p=.980) 
.192 
(p=.195) 
-.001 
p=.993) 
.119 
(p=.425) 
.192 
(p=.192) 
.140 
(p=.344) 
.093 
(p=.528) 
.074 
(p=.619) 
VWF  
baseline 
-.011 
(p=.939) 
.076 
(p=.599) 
.074 
(p=.610) 
.219 
(p=.130) 
-.118 
p=.416) 
-.011 
(p=.941) 
.110 
(p=.449) 
-.038 
(p=.795) 
.104 
(p=.470) 
-.051 
(p=.726) 
VWF 
(N=22) 
post-stress 
-.128 
(p=.742) 
-.276 
(p=.472) 
.097 
(p=.804) 
-.122 
(p =.754) 
-.101 
(p=.796) 
.322 
(p =. 437) 
.224 
(p =.563) 
-.339 
(p =.372) 
-.063 
(p=.872) 
-.131 
(p=.736) 
VWF 
(N=63) 
+15 min 
-.197 
(p=.176) 
r=-.269 
(p=.061) 
-.020 
(p=.892) 
.037 
(p =.800) 
-.041 
(p=.777) 
-.137 
(p =.354) 
.037 
(p=.803) 
-.120 
(p =.413) 
-.076 
(p=.602) 
-.178 
(p=.220) 
PAI-1 
(N=63) 
-.246 
(p=.082) 
-.214 
(p =.132) 
-.113 
(p= .428) 
-.087 
(p=.550) 
-.117 
(p=.313) 
-.214 
(p =.135) 
-.153 
(p =.283). 
-.157 
(p =.270) 
-.313 
(p=.025) 
-.254 
(p=.072) 
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6. Discussion 
This works’ focus lies on whether or not a history of major depression or current chronic 
stress affect the hemostatic system at rest and after an acute stressor. Furthermore, the ques-
tion whether depression history and chronic stress influence coagulation independent of each 
other or have interacting effects was examined.  
 
In summary, the key findings were that subjects with a history of depression had higher rest-
ing fibrinogen levels and, additionally, that acute stress-induced changes in fibrinogen were 
affected by a history of depression. Furthermore, it was shown that chronic stress load signifi-
cantly affected D-Dimer changes brought about by the TSST. The combination of CS with 
MD showed a trend toward significance in influencing stress-induced D-Dimer changes.  
 
The following sections will elaborate on the hypotheses that are listed in part 3 of this work, 
together with the related findings, closing with a discussion of the limitations of this study, as 
well as an outlook to further required research.  
6.1. Coagulation markers at rest 
6.1.1. The effects of remitted depression on basal coagulation 
The remitted depression group presented with higher baseline fibrinogen levels than the con-
trol group, which confirms our hypothesis H1.1. for fibrinogen. This hypothesis stated that 
baseline fibrinogen and PAI-1 levels are higher in persons with a history of depression, com-
pared to controls. For PAI-1 levels, however, there were no differences between the groups.  
 
The present data supports hypothesis H1.1. for fibrinogen, but not for PAI-1. 
 
Previous research on fibrinogen also found a positive association between resting fibrinogen 
levels and depression (Hjemdahl & Von Känel, 2012; Wium-Andersen, Orsted et al., 2013) 
and interestingly, according to the results of the present study, this association seems to per-
sist after remission of depression. The subjects in the remitted depression group experienced 
their last episode on average 10.5 years prior to this assessment, but still, fibrinogen remained 
elevated even when depressive symptoms were absent or at subclinical levels. These findings 
add to the hypothesis that fibrinogen might serve as a marker for depression, as other  
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researchers suggest (Martins-de-Souza et al., 2014; Okwuosa et al., 2013; Wium-Andersen, 
Orsted et al., 2013). Increased fibrinogen levels in remitted depression may confer an in-
creased risk for cardiovascular disease, without the presence of the traditional cardiovascular 
risk factors. Notably, it has been reported that there exists a strong independent correlation 
between changes in traditional cardiovascular risk factors and changes in mean fibrinogen. 
(Okwuosa et al., 2013). It remains open whether these relationships hold true also for persons 
with depression or depression history.  
Regarding PAI-1, there were no differences between remitted depressed subjects and controls. 
PAI-1 has a diurnal variation, with highest levels in the morning (Angleton, Chandler, & 
Schmer, 1989) and since the TSST was carried out in the afternoon, this might be one reason 
for our negative result. Another reason for our negative result may be that PAI-1 appears to be 
only associated with remitted depression in aged patients, as one recent study indicates. The 
subjects in that study were between the ages of 70 and 90 years (Baune et al., 2012). Howev-
er, in our work, subjects were on average in their mid-thirties. The exact role of PAI-1 in re-
mitted depression needs to be further investigated.  
6.1.2. The effects of chronic stress on basal coagulation 
At rest, persons with high chronic stress showed a trend toward higher D-Dimer plasma con-
centrations.  
 
Hypothesis H1.2., which states that persons under high chronic stress show elevated co-
agulation parameters at rest, cannot be supported for any of the considered markers, 
namely fibrinogen, D-Dimer, VWF and PAI-1, albeit a trend is seen for D-Dimer.  
 
Increased D-Dimer concentrations suggest that chronically stressed persons may have in-
creased fibrin turnover. Elevated D-Dimer levels have been reported in a variety of diseases, 
such as venous thrombosis (Cushman et al., 2003), ischemic heart disease (Lowe et al., 2004) 
and even in cancer patients (Ay et al., 2012). Recently, a large study found that even in a 
healthy population free of cardiovascular risk factors, elevated D-Dimer levels were inde-
pendently associated with increased mortality (multivariable hazard ratios ranged between 
1.06 and 1.97). These findings linking increased D-Dimer plasma concentrations to increased 
mortality together with the results from our study suggest that further research on the connec-
tions between chronic stress and D-Dimer is needed.  
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Our results could not reproduce the findings regarding fibrinogen, the endothelial-dysfunction 
marker VWF and the anti-fibrinolytic marker PAI-1 that other studies have reported. This 
may have various reasons: the other studies did not assess chronic stress in the same way as 
was done in this study, i.e. using the TICS questionnaire. They studied the stress of caregiving 
for demented patients, job stress and traumatic life events, separately, and did not assess over-
all chronic stress, as the TICS does. 
6.1.3. Interaction effects between remitted depression and chronic stress on basal 
coagulation 
In hypothesis 1.3., it was stated that in previously depressed subjects, procoagulant parame-
ters at baseline are altered, depending on the presence of chronic stress. 
 
In this study no interaction effects between chronic stress and a history of major depres-
sion on baseline procoagulant markers could be found, and thus, hypothesis 1.3. cannot 
be supported.  
 
It appears that in its effect on basal coagulation, a positive depression history is independent 
from chronic stress. Because depression is often accompanied and worsened by chronic stress, 
and in turn, chronic stressful life situations can increase the risk of developing depression, it 
was plausible to speculate that interacting effects of CS and MD existed. However, in remit-
ted depression, as examined in this work, this interaction does not seem to exist regarding 
baseline levels.  
6.2. Stress-induced changes 
The stress test elicited a reliable stress reaction as indicated by rising cortisol levels and the 
subjects’ feelings of perceived stress. On average, heart rate changed significantly from pre- 
to post-stress as an indicator of an activation of the SAM-system. When looking at the repeat-
ed measures analysis of covariance, heart rate changes over all time points were not signifi-
cant. This result is not surprising, since TSST is known to more reliably trigger HPA-axis 
responses than responses of the sympathetic nervous system (Dickerson & Kemeny, 2004). 
Cortisol increases as part of a positive HPA-axis response were indeed significant. There are 
many elements in the TSST which seem uncontrollable to the subjects and cortisol is known 
to respond more with uncontrollable situations than with controllable ones (Hamer & Malan,  
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2010). Although not significant, the observation that the chronic stress group without a histo-
ry of depression (MD-CS+) had the highest overall cortisol levels is noteworthy. Whereas 
chronic stress without a depression history shows a higher cortisol curve, the curve for the 
combination of chronic stress plus depression history runs lower. Beside its effects on auto-
nomic functions, the TSST also influenced subjects’ anxiety levels considerably. As expected, 
subjects reported that they felt more anxious during the stress test than before and that their 
anxiety decreased again during the recovery period.  
 
The TSST also elicited changes in the hemostatic system: in all subjects unrelated to group, a 
trend toward an increase in D-Dimer levels was observed during the TSST, with average  
levels increasing by almost one third from pre- to post-TSST. A possible reason for why this 
increase was not significant may be that the post-stress measurement took place 15 minutes 
after, and not directly post-stress. It is possible that D-Dimer levels had already decreased 
again after this time.  
6.2.1. The effects of remitted depression on stress-induced coagulation 
To date, no other studies have examined remitted depression in relation to stress-induced 
changes of coagulation parameters. In the present study, fibrinogen levels decreased slightly 
in all but one of the four groups as a reaction to the TSST. In the MD-CS+ group, levels in-
creased slightly. Depression history accounted for this change.  
In a smaller sample of subjects for which the three parameters of interest were measured di-
rectly after the TSST (N=22), this depression effect remained. However, a stress-induced in-
crease of fibrinogen, as reported by other studies, could not be seen here. Instead, a slight de-
crease was observed. A possibility for fibrinogen levels not increasing with the stressor could 
be an increased consumption of fibrinogen due to in-situ fibrin formation on the surface of 
blood vessels (Von Känel, Kudielka et al., 2009). However, despite the fact that fibrinogen 
did not increase, depression history had a significant effect on stress-induced fibrinogen levels 
over time: in subjects with a depression history, fibrinogen levels decreased after the stress 
test.  
No effects of remitted depression on any of the other procoagulant markers could be ob-
served.  
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Hence, hypothesis 2.1., which states that a history of depression has an effect on stress-
induced D-Dimer changes, is not supported.  
Previous findings focussing on D-Dimer stress-responsiveness and depression provided a 
mixed picture as both an attenuated response immediately post-stress (Von Känel, 
Bellingrath, et al., 2009b) and increases (Wirtz et al., 2008) have been reported. These studies 
included subjects with depression symptoms at the time of the experiment (TSST). We were 
not able to reproduce any of the previous results. In this work depression history did not have 
an effect on D-Dimer changes, possibly because this study examined persons without current 
depression symptoms. Nevertheless, the effect of depression history on fibrinogen levels was 
a significant one, as is described above.  
 
6.2.2. The effects of chronic stress on stress-induced coagulation 
Individuals with high chronic stress had significantly higher D-Dimer changes following the 
stress test than those without chronic stress.  
 
Hypothesis H2.2., which states that high chronic stress modulates procoagulant respons-
es to acute psychosocial stress, is therefore supported. D-Dimer was the only parameter 
that was affected by chronic stress, while fibrinogen and VWF were unaffected. 
 
Notably, the effect of chronic stress on D-Dimer was only true for our larger sample for 
which three measurements were taken. In the smaller sub-sample, for which four measure-
ments were taken, the effect of chronic stress on D-Dimer changes was no longer significant. 
This might be explained by the relatively small size of the sub-sample. 
A D-Dimer increase indicates augmented production of thrombin and fibrin like during the 
formation of a thrombus. Also, as a thrombus is broken down, fibrin dissolves into D-Dimers 
and D-Dimer concentration increases. D-Dimer can be viewed as a marker for both fibrin 
formation and degradation. D-Dimer levels rose in all subjects after the TSST, independent of 
group, indicating that a hypercoagulable state had been reached briefly. The increase was 
most pronounced when chronic stress was present, i.e. in the MD-CS+ group and the 
MD+CS+ group.  
Fibrin D-Dimer is considered an independent marker of the risk of cardiovascular disease and 
is also related to atherosclerosis severity (Zhou et al., 2007).  In light of this known  
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relationship, the present results suggest that persons suffering from chronic stress may be 
more prone to develop atherosclerosis or that pre-existing atherosclerotic lesions may develop 
faster.  
6.2.3. Interaction effects between remitted depression and chronic stress on stress-
induced coagulation 
With respect to our hypothesis regarding the interaction effects between remitted MD and CS 
on stress-induced coagulation, we found that there was a trend only for D-Dimer levels to be 
affected by the CS/MD interaction. None of the other markers that were examined were af-
fected by the CS/MD interaction. Those subjects with both chronic stress and a history of de-
pression tended to have greater D-Dimer changes over the different time points, but the inter-
action did not reach significance.  
 
Hypothesis H2.3., which states that interacting effects of CS and MD history on stress-
induced coagulation exist, is not supported for fibrinogen, D-Dimer and VWF.  
 
Nonetheless, a trend for D-Dimer changes to be affected by a CS x MD interaction was found.  
This result suggests that chronic stress may be a mediator of the association between depres-
sion and D-Dimer change. In turn, depression history could be a mediator of the association 
between chronic stress and D-Dimer change following an acute stressor.  
6.3. Associations between chronic stress and hemostasis 
We carried out observational partial correlation analyses to examine if chronic stress load and 
current depressive symptoms were associated with any of the hemostatic factors at rest and 
post-stress. The score on the BDI-II, which was used to detect depression symptoms, was not 
associated with any of the coagulation parameters, possibly because all subjects were in re-
mission and had sub-clinical scores. Some elements of the TICS questionnaire showed signif-
icant correlations with the measured coagulation factors.  
Perhaps the most interesting association that was observed here is that fibrinogen and the 
screening score for chronic stress show an inverse relationship: the chronic stress screening 
score correlated negatively with fibrinogen measured immediately post-stress, as well as 15 
minutes post-stress. A high chronic stress burden could be associated with lower fibrinogen  
levels.  However, an interpretation of these results is difficult, because for the significant as-
sociation the sample size was rather small (N=22) to draw conclusions, while for the  
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15 minutes post-stress measurement (N=63), the correlation was weak and did not reach sig-
nificance. However, it is possible that a high chronic stress load somehow suppresses fibrino-
gen levels after an acute stressor, perhaps by increasing its turnover to fibrin.  
Previous research on the anti-fibrinolytic marker PAI-1 has found it to be positively associat-
ed with chronic stress but we were not able to reproduce these results.  
As mentioned earlier, we intended these correlation analyses to have explorative character. 
Larger sample sizes would be required to reveal further effects.  
 
6.4. Strengths and limitations 
As already mentioned in the preceding chapters, interpretation of our findings must take into 
account certain choices made and limitations present. These are summarized in the following, 
addressing sample selection, study protocol, technical protocol execution and potential influ-
ences of stress hemoconcentration. 
 
Having recruited subjects from the EDSP study, which includes a well-characterized epide-
miological sample, one can assume an overall high quality of the subsample used in this 
study. 
The influence of smoking and oral contraceptives were not defined as exclusion criteria since 
it would have created great difficulties in the recruitment of subjects. However, both have 
known influences on the hemostatic system. Fibrinogen and PAI-1 activity have been shown 
to be higher in previous and current smokers compared to persons who never smoked 
(Lahlou-Laforet et al., 2006) and women taking oral contraceptives are more prone to deep 
venous thrombosis. Contraception and smoking status were therefore used as covariates in the 
analyses. In the present sample there were no statistical differences in the number of smokers 
and women taking oral contraceptives between the groups. The inclusion of the four subjects 
who were taking antidepressant medication merits critical attention as well since an influence 
on the coagulation system is possible. We therefore accounted for its influence by using anti-
depressant medication as a covariate in all analyses.  
 
All persons involved in the experimental part of the study adhered to a strict protocol that 
listed all steps. Instructions regarding the TSST were read out loud to minimize inconsisten-
cies and ambiguities due to the investigator’s interaction with the test subjects. This ensured 
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that the TSST was carried out in a highly standardized manner. Other strong points of this 
work were the location of the experiment in a soundproof room and a system that allowed for 
blood collection through the wall without disturbing the participant.  
Regarding the time points for measurement of the four coagulation markers, one limitation 
was that in the initial study protocol, the first post-TSST blood sample would be taken 15 
minutes after the TSST. Based on expert consultations during the study, we added another 
time point to the study protocol immediately post TSST. The amended study protocol with the 
additional measurement of coagulation factors was then implemented for the remaining 22 
subjects of the sample (of a total of 63). For these 22 subjects, however, group distribution 
was uneven, with only 7 subjects in the remitted depression group. Statistical analyses were 
carried out for both, the complete and the N=22 sample, as described in chapter 4. For the 
N=22 sample, both the small sample size, as well as the uneven distribution among the 
MD/CS groups decreases the statistical power of the outcomes and any interpretations regard-
ing these results should be viewed with a degree of caution. Still, the results from the com-
plete and the N=22 samples are directionally equal for the following analyses: the depression 
effect on fibrinogen changes, the negative effect of TSST on D-Dimer levels, the negative 
effect of depression on D-Dimer levels, and all analyses regarding VWF. The two samples 
differed in the following results: the CS effect on D-Dimer and the TSST effect on fibrinogen 
were significant for the larger sample, but not for the smaller one.  
 
Technical problems and delays could not be prevented in some cases. Baseline measures were 
taken after a 30-minute time period during which the subjects were able to acclimatize to the 
new setting. In some cases this time period may have been shortened, e.g. due to difficulties 
with placing the venous catheter or because subjects experienced circulatory problems. Thus, 
there were minor deviations in the subjects’ starting conditions.  Further, some of the post-
stress blood collections may have been slightly delayed. Clogging of the catheter were likely 
reasons for this, and in some cases the placement of a new catheter became necessary.  
 
Hemoconcentration is another possible process that may have an influence on stress-induced 
coagulation since it may influence the concentration of hemostatic components. As coagula-
tion factors are relatively large molecules they cannot move passively through the vessel wall 
to the extravascular space (Austin et al., 2011; Hjemdahl & Von Känel, 2012). As plasma 
shifts from the intra- to the extravascular space during acute stress, the concentration of  
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non-diffusible molecules rises (Allen & Patterson, 1995). This process is likely caused by an 
increase in blood pressure through SNS activation. It is important to think about this concept 
when studying coagulation changes since rising coagulation factor concentrations may be 
genuine effects of stress but they may also be due to plasma loss (Hjemdahl & Von Känel, 
2012). A review of the relevant literature (Austin & Patterson, 2013) concludes that stress-
induced changes in coagulation are due to both hemoconcentration and actual activation of 
coagulation and that the intrinsic pathway (as seen in FXIII) is likely genuinely activated by 
acute stress. It is not yet clear to what extent hemoconcentration needs to be accounted for 
and adjusted for arithmetically when studying stress-induced coagulation parameters. There 
are different methods for hemoconcentration-correction: an arithmetic correction, a baseline 
plasma reconstitution method and a reconstitution method using saline (Austin & Patterson, 
2013). The most accurate method is currently being debated, and correction techniques have 
consequently not been included in this study.  
6.5. Conclusion and outlook 
Depression and chronic stress often form a vicious cycle, with chronic stress increasing de-
pressive symptoms and depressive symptoms causing further stress. It is therefore relevant to 
determine whether chronic stress and depression are independent in their effect on the hemo-
static system or whether they interact to create a hypercoagulable environment.  
The present study thus intended to find out if patients who had suffered from major depres-
sion in the past but were in remission at the time of the experiment also showed alterations in 
hemostatic function, at rest and following acute stress. Furthermore, the influence of chronic 
stress and the combination of remitted depression and chronic stress was examined in the 
same way. First, the findings regarding fibrinogen are discussed, and then the findings regard-
ing D-Dimer. 
 
This work found that remitted depressed subjects in their mid-thirties had higher fibrinogen 
levels at rest than controls, with no change in D-Dimers. With regard to interaction effects 
between remitted depression and chronic stress on resting coagulation markers, our results are 
negative, implying that depression history and chronic stress are independent factors to influ-
ence the hemostatic system. 
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When remitted depressed participants were subjected to an acute psychosocial stressor, we 
found that their stress-responsiveness was different from healthy controls, i.e. that different 
effects on the concentration of coagulation factor fibrinogen and its development over time 
were observed. Our findings therefore support the association between major depression and 
elevations of fibrinogen levels – while other studies focused on acute depression, this study 
found this association to also hold true in remitted depression. 
 
High blood pressure, dyslipidemia, smoking status and diabetes are known cardiovascular risk 
factors. Heightened fibrinogen has been identified as one of them and has been shown to also 
be elevated in depression. Notably, in depression, the risk for cardiovascular disease is in-
creased, independent of the other cardiovascular risk factors. Fibrinogen therefore appears to 
be a common denominator in both classical risk factors and depression. The present results 
demonstrate that depression history is associated with altered hemostasis function when the 
two potentially confounding biological variables, BMI and smoking, both of which are related 
to metabolic syndrome, were taken into account. Positive correlations between fibrinogen 
levels and the known cardiovascular risk factors high BMI, high triglycerides and LDL cho-
lesterol, low HDL, diabetes history and hypertension history have been reported (Kaptoge et 
al., 2007b). In a meta-analysis on healthy middle-aged adults, Danesh et al. (2001) also report 
associations between plasma fibrinogen levels and the risks for coronary heart disease and 
stroke. Again, fibrinogen generally increased with BMI, LDL-cholesterol, log triglycerides 
and diastolic blood pressure and fell with increasing physical activity and HDL-cholesterol 
(Danesh et al., 2001).  
 
Since fibrinogen is a major acute-phase-protein, an increase could also indicate a state of in-
flammation. Whether increased resting fibrinogen levels reflect an increased state of inflam-
mation or whether fibrinogen is elevated through pathophysiological processes caused by 
depression is unclear. Work on inflammatory markers revealed elevated levels of the cyto-
kines TNF-alpha and IL-6 in depressed patients (Dowlati et al., 2010) and another study con-
cluded that the inflammation marker C-reactive protein (CRP) and the cytokines IL-1 and IL-
6 were associated with depression (Howren, Lamkin, & Suls, 2009). Furthermore, a strong 
positive correlation between CRP levels and fibrinogen has been described (Kaptoge et al., 
2007b).   
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Our finding regarding increased baseline fibrinogen in remitted depression lends further sup-
port to fibrinogen as being a potential depression marker.  A recent study by Martins-de-
Souza et al. (2014) investigated whether fibrinogen may serve as a marker for antidepressant 
treatment response. Non-responders to antidepressant medication had higher fibrinogen levels 
compared to responders. Successful treatment of depression may therefore possibly lower the 
cardiovascular risk by lowering fibrinogen. Behavioral changes, such as smoking cessation 
and weight loss have been shown to also decrease fibrinogen levels in young, healthy adults 
(Okwuosa et al., 2013). As a consequence, it would be advisable that physicians treating de-
pression have knowledge about their patients’ cardiovascular risk factors and that they give 
depression, and also remitted depression, the same amount of attention as a traditional cardio-
vascular risk factor. One should also consider monitoring fibrinogen in depressed patients as a 
real option in the future. 
 
Our second major finding was that a trend was seen for subjects under chronic stress to have 
increased D-Dimer levels at rest, however for fibrinogen there was no such elevation seen. 
Once all subjects underwent the acute stress test, their average D-Dimer concentrations in-
creased significantly, with the factor chronic stress having a significant effect on these  
changes.   
 
Previous research using the TICS questionnaire, which was also used in this study, reports 
that depressive symptoms, burnout syndrome and sleep disturbances are more common in 
people who have high levels of chronic stress than in those without high levels of stress. 
(Hapke et al., 2013). Whether scores on the TICS are also positively related to increased car-
diovascular events remains open and would be worth examining. Adults experiencing social 
isolation and workplace stress situations that can be considered chronic stress factors, have 
been shown to have an increased risk for coronary heart disease (Steptoe & Kivimäki, 2012). 
These facts make the assumption plausible that high TICS scores are associated with in-
creased cardiovascular disease. A possible reason for chronic stress being linked to coronary 
heart disease may be a hypercoagulable state, which is underlined by higher D-Dimer levels, 
as was found here. Prospective studies are needed to assess whether persons with high chronic 
stress, as measured by the TICS, have increased cardiovascular risk, particularly since they 
also showed alterations of D-Dimer levels.  
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The risk of cardiovascular disease and insults in chronically stressed individuals may be con-
siderably reduced through interventional measures such as relaxation techniques and  
stress management, however, more studies in this area are needed. Social support seems to be 
another key factor to protect against chronic stress and its negative effects on health. Social 
support and chronic stress show an inverse relationship (Hapke et al., 2013), which needs to 
be considered as a key element in public health measures. The existing studies on pharmaco-
logical interventions to restore normal hemostatic function appear to be somewhat limited in 
scope, as a review by Austin et al. (2013) showed. More research on pharmacological, as well 
as behavioral measures would be useful to further assess whether these can influence stress-
related hypercoagulability, and thus possibly sever the psychosomatic connections between 
stress and cardiovascular risk.  
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Appendix I. 
The following tables show the raw data presented in the Results section (Section 5).  
 
Source data for Figures 4, 5, 6 and 7.  
Mean baseline concentrations of fibrinogen, D-Dimer, VWF and PAI-1. Comparison between 
subjects with remitted depression and without a history of depression. Comparison between 
subjects with and without chronic stress and interaction effects.  
Fibrinogen 
(mg/dl) 
MD- (N=24) MD+ (N=39)  CS-  (N=29) CS+ (N=34)  
MD*CS  
(interaction) 
111.192 
(±5.988) 
126.742 
(±3.567) 
F1,50=7.738 
p=.008 
118.069 
(±5.076) 
123.235 
(±4.403) 
F1,50=.139 
p=.711 
F1,48=.184 
p=.670 
D-Dimer 
(ng/ml) 
MD- (N=23) MD+  (N=38)  CS- (N=28) CS+ (N=33)   
57.609 
(±22.223) 
56.077 
(±11.518) 
F1,48=.209 
p=.649 
38.464 
(±13.060) 
70.303 
(±16.820) 
F1,48=2.96 
p=.092 
F1,48=2.570 
p=.115 
VWF 
(mg/L) 
MD- (N=24) MD+ (N=38)  CS- (N=28) CS+ (N=34)   
11.628 
(±1.475) 
11.915 
(±.610) 
F1,49=.203 
p=.654 
11.711 
(±.954) 
11.805 
(±.971) 
F1,49=.450 
p=.505 
F1,48=.626 
p=.432 
PAI1 
(ng/ml) 
MD- (N=24) MD+ (N=39)  CS- (N=29) CS+  (N=34)   
1.648  
(±.187) 
2.072 
(±.234) 
F1,50 =.246 
p=.622 
1.919 
(±.266) 
1.903 
(±.209) 
F1,50=.837 
p=.365 
F1,48=.308 
p=.581 
 
Source data for Figure 8. 
Mean heart rate measures (bpm) of the four groups before and after the TSST. The figure 
shows means and standard errors corrected for baseline differences.  
 Rest Instruction pre-TSST post-TSST +15min +30min +45min 
MD+CS+  
(N=18) 
80.680 
(±2.222) 
82.280 
(±2.181) 
96.390 
(±2.180) 
98.170 
(±2.324) 
75.890 
(±1.473) 
75.390 
(±1.732) 
77.170 
(±2.071) 
MD+CS-    
(N=18) 
81.370 
(±3.686) 
81.720 
(±3.457) 
94.390 
(±3.918) 
98.940 
(±4.290) 
78.440 
(±2.381) 
74.830 
(±2.914) 
74.720 
(±2.670) 
MD-CS+   
(N=12) 
77.000 
(±3.213) 
84.250 
(±4.143) 
100.170 
(±4.026) 
102.670 
(±4.760) 
74.250 
(±3.170) 
74.580 
(±2.684) 
72.000 
(±3.245) 
MD-CS- 
(N=9) 
83.560 
(±4.167) 
81.440 
(±4.240) 
101.560 
(±1.923) 
104.330 
(±4.187) 
82.890 
(±4.053) 
79.220 
(±3.045) 
75.670 
(±2.872) 
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Source data for Figure 9. 
Cortisol response (ng/ml) separate for each of the four groups. Means and standard errors 
corrected for baseline differences. 
 Baseline pre-TSST post-TSST +15min +30min +45min 
MD+CS+ 
(N=19) 
127.296 
(±28.464) 
118.510 
(±9.323) 
134.360 
(±9.789) 
122.790 
(±10.480) 
104.720 
(±8.828) 
91.940 
(±7.706) 
MD+CS- 
(N=17) 
118.378 
(±27.158) 
124.710 
(±15.231) 
153.550 
(±13.444) 
141.310 
(±11.809) 
122.070 
(±11.038) 
109.140 
(±10.182) 
MD-CS+ 
(N=14) 
150.069 
(±18.119) 
144.850 
(±15.953) 
168.250 
(±12.588) 
159.970 
(±16.073) 
144.150 
(±14.739) 
130.070 
(±12.505) 
MD-CS- 
(N=10) 
133.608 
(±13.734) 
122.890 
(±8.684) 
152.910 
(±7.577) 
147.980 
(±9.949) 
129.970 
(±10.028) 
115.830 
(±9.284) 
 
Source data for Figure 10.   
Changes in perceived anxiety during the stress protocol. Presented are estimated BSKE score 
means and standard errors corrected for baseline differences. 
A: subscore ‘inner restlessness’ , B: subscore ‘anxiety’.  
 
A: (effect of TSST: F3.6, 198.8=55.208, p<.001); 
 
 
 
 
Baseline Instruction pre-TSST TSST +15min +30min +45min 
MD+CS+ 
(N=20) 
2.100 
(±.204) 
2.800 
(±.296) 
3.050 
(±.276) 
4.000 
(±.299) 
1.250 
(±.289) 
.750 
(±.190) 
.800 
(±.200) 
MD+CS 
(N=18) 
1.530 
(±.298) 
2.110 
(±.290) 
2.440 
(±.217) 
3.890 
(±.179) 
.940 
(±.221) 
.670 
(±.243) 
.560 
(±.145) 
MD-CS+ 
(N=13) 
1.930 
(±.384) 
2.380 
(±.367) 
3.380 
(±.331) 
4.460 
(±.215) 
1.150 
(±.317) 
.850 
(±.222) 
.690 
(±.263) 
MD-CS- 
(N=10) 
2.100 
(±.379) 
2.700 
(±.367) 
3.600 
(±.452) 
4.400 
(±.400) 
1.500 
(±.401) 
.800 
(±.291) 
.800 
(±.291) 
 
B: (effect of TSST: F2.4, 133.6=25.666, p<.001) 
 Baseline Instruction pre-TSST TSST +15min +30min +45min 
MD+CS+ 
(N=20) 
.650 
(±.167) 
1.500 
(±.295) 
1.850 
(±.318) 
2.300 
(±.430) 
.450 
(±.185) 
.300 
(±.128) 
.300 
(±.128) 
MD+CS- 
(N=18) 
.420 
(±.163) 
.720 
(±.278) 
0.940 
(±.297) 
1.390 
(±.257) 
.390 
(±.183) 
.170 
(±.121) 
.220 
(±.101) 
MD-CS+ 
(N=13) 
.570 
(±.260) 
1.000 
(±.408) 
2.000 
(±.453) 
2.000 
(±.438) 
.690 
(±.308) 
.230 
(±.122) 
.230 
(±.122) 
MD-CS- 
(N=10) 
.300 
(±.153) 
.500 
(±.307) 
1.100 
(±.482) 
1.500 
(±.500) 
.200 
(±.200) 
.100 
(±.100) 
.000 
(±.000) 
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Source data for Figure 11.  
Changes in the three coagulation parameters in response to the TSST (N=63), independent of 
group. The table depicts means and standard errors with F and p-values (repeated measures 
ANCOVA with two independent factors, MD and CS). 
 baseline +15min +45min 
effect of 
TSST 
effect of 
MD 
effect of 
CS 
Effect of 
MD*CS 
Fibrinogen 
(mg/dl) 
120.781 
(±3.270) 
116.206 
(±4.011) 
115.841 
(±3.855) 
F1.9,94.2=4.076 
p=.021 
F1,49=7.850 
p=.007 
F1,49=.052 
p=.820 
F1,49=.000 
p=.993 
D-Dimer 
(ng/ml) 
56.645 
(±10.866) 
78.951 
(±12.000) 
53.049 
(±10.582) 
F1.6,76.6=.099 
p=.868 
F1,47=.008 
p=.930 
F1,47=4.107 
p=.048 
F1,47=3.880 
p=.055 
VWF 
(mg/L) 
11.805 
(±.670) 
13.162 
(±.611) 
13.246 
(±.538) 
F1.5,70.9=1.643 
p=.205 
F1,48=.724 
p=.399 
F1,48=.302 
p=.585 
F1,48=.048 
p=.828 
 
Changes in the three coagulation parameters in response to the TSST (N=22), independent of 
group. Repeated measures ANCOVA with two independent factors, MD and CS. 
 effect of TSST effect of MD effect of CS 
Fibrinogen  F1,10<=.453 
p>=.516 
F1,10=6.042 
p=.034 
F1,10 =.506 
p=.493 
D-Dimer F1,10 <=1.617  
p>=.232 
F1,10=2.560 
p =.141 
F1,10 =2.627 
p=.136 
VWF F1,9<=1.722 
p>=.222 
F1,9=.603 
p=.457 
F1,9=.281 
p =.609 
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Source data for Figure 12.  
Baseline to post-stress measures of fibrinogen (mg/dl) in the four groups. Presented are means 
with standard errors. 
 baseline +15min +45min 
MD+CS+  
(N=20) 
131.55 
(±5.177) 
125.15 
(±6.515) 
122.55 
(±6.451) 
MD+CS-   
(N=18) 
121.61 
(±5.304) 
116.17 
(±5.623) 
115 
(±5.813) 
MD-CS+   
(N=14) 
111.36 
(±6.715) 
112.79 
(±8.507) 
116.14 
(±8.769) 
MD-CS-    
(N=10) 
111.2 
(±11.347) 
104.7 
(±15.107) 
102.6 
(±12.974) 
 
Source data for Figure 13. 
Baseline to post-stress measures of fibrinogen (mg/dl), including another post-stress time 
point (immediately post-TSST). Presented are means and standard errors. 
 baseline post-TSST +30min +45min 
MD+ 
(N=7) 
129.857  
(±6.978) 
116.571 
(±9.954) 
116.571 
(±8.375) 
121.286 
(±14.484) 
MD- 
(N=15) 
109.600 
(±7.105) 
111.200 
(±10.087) 
113.667 
(±10.145) 
110.133 
(±9.805) 
CS+ 
(N=15) 
114.000 
(±5.928) 
113.800 
(±8.478) 
113.467 
(±7.600) 
114.133 
(±9.151) 
CS- 
(N=7) 
120.429 
(±12.934) 
111.000 
(±15.837) 
117.000 
(±17.191) 
112.714 
(±16.903) 
 
Source data for Figure 14. 
Baseline to post-stress measures of D-Dimer (ng/ml) in the four groups. Presented are means 
and standard errors.  
 baseline +15min +45min 
MD+CS+ 
(N=19) 
59.160 
(±14.811) 
78.950 
 (±19.471) 
45.790 
 (±12.338) 
MD+CS- 
(N=18) 
49.500 
(±19.566) 
56.500 
 (±18.425) 
37.440 
 (±14.746) 
MD-CS+ 
(N=14) 
85.430 
(±34.624) 
138.140 
 (±33.369) 
90.860  
(±37.102) 
MD-CS- 
(N=9) 
14.330  
(±7.474) 
34.110 
 (±14.045) 
38.780  
(±13.534) 
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Source data for Figure 15.  
Baseline to post-stress measures of D-Dimer (ng/ml). including another post-stress time point 
(immediately post-TSST). Presented are means and standard errors. 
 baseline post-TSST +15min +45min 
MD+  
(N=7) 
82.230 
(±34.981) 
105.430 
(±36.840) 
177.857 
(±35.273) 
96.714 
(±38.757) 
MD-  
(N=15) 
56.400 
(±32.184) 
154.400 
(±65.490) 
111.133 
(±32.540) 
80.933 
(±33.330) 
CS+ 
(N=15) 
70.400 
(±34.446) 
151.930 
(±66.786) 
150.733 
(±33.563) 
79.667 
(±34.874) 
CS- 
(N=7) 
52.230 
(±22.557) 
110.710 
(±24.057) 
93.000 
(±32.146) 
99.429 
(±30.977) 
 
Source data for Figure 16.  
Baseline to post-stress measures of VWF (mg/L). Presented are means and standard errors, 
separate for the four groups.  
  baseline +15min +45min 
MD+CS+    
(N=20) 
11.400 
(±.843) 
12.740 
(±1.152) 
13.090 
(±.999) 
MD+CS-     
(N=17) 
12.370 
(±.987) 
14.750 
(±.832) 
14.640 
(±1.123) 
MD-CS+     
(N=14) 
12.390 
(±2.070) 
11.680 
(±1.466) 
11.850 
(±1.042) 
MD-CS-      
(N=10) 
10.560 
(±2.114) 
13.360 
(±1.672) 
13.200  
(±1.436) 
 
Source data for Figure 17.  
Baseline to post-stress measures of VWF (mg/L), including another time point (immediately 
post-TSST). Presented are means and standard errors.  
 baseline post-TSST +15min +45min 
MD+    
(N=6) 
10.680 
(±1.428) 
9.330 
(±1.564) 
9.680 
(±1.817) 
9.910 
(±.882) 
MD-     
(N=15) 
11.000 
(±1.815) 
10.700 
(±.926) 
11.200 
(±1.425) 
11.550 
(±.788) 
CS+    
(N=15) 
11.150 
(±1.819) 
9.917 
(±1.032) 
10.270 
(±1.350) 
10.980 
(±.827) 
CS- 
(N=6) 
10.300 
(±1.353) 
11.410 
(±.980) 
12.020 
(±2.154) 
11.340 
(±.838) 
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Appendix II. 
The following table shows further results of the partial correlation analysis between the coag-
ulation parameters and the BDI-II score that were not presented in the text. 
FIB: fibrinogen  
DD: D-Dimer  
VWF: Von-Willebrand-Factor  
PAI1: plasminogen activator inhibitor type 1  
bdi_tsst: score on the BDI-II on the test day 
time points were G1: baseline, G2: +15 min, G3: +45 min, G4: immediately post-TSST.  
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The following tables shows results of the partial correlation analysis carried out between 
scores on the TICS questionnaire and the selected coagulation markers. Measurements at +45 
minutes post-stress were not shown in Table 5 of the results section, but are presented here.  
FIB: fibrinogen levels  
D-Dimer levels  
VWF: Von-Willebrand-Factor levels  
PAI1: plasminogen activator inhibitor type 1  
bdi_tsst: score on the BDI-II on the test day 
time points were G1: baseline, G2: + 15 min, G3: +45 min, G4: immediately post-TSST. 
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